» 20th International Congress
- 12:30pm-2:00pm
-
“Two odd targets” strategy in deep brain stimulation for Parkinson’s disease with unilateral dystonia
- 12:30pm-2:00pm
-
"Atypical" atypical parkinsonism
- 12:30pm-2:00pm
-
1-year clinical outcomes in patients with parkinsonism syndrome with/without type 2 diabetes
- 12:30pm-2:00pm
-
A case of PD with non -motor symptoms onset
- 12:30pm-2:00pm
-
A case of thalamic malignant glioma formation in a patient with STN-DBS for Parkinson’s disease
- 12:30pm-2:00pm
-
A case series of sigmoid volvulus in Parkinson’s disease
- 12:30pm-2:00pm
-
A cognitive monitoring program for individuals with Parkinson’s disease submitted to deep brain stimulation
- 12:30pm-2:00pm
-
A comparison study of health-related quality of life between female and male patients with Parkinson’s disease
- 12:30pm-2:00pm
-
A cross-sectional study of sensor-based gait analysis in atypical Parkinsonian disorders
- 12:30pm-2:00pm
-
A dopamine-dependent activity of the STN in the control of balance in Parkinson’s disease
- 12:30pm-2:00pm
-
A longitudinal observational study of a cohort of patients with PSP/CBD: The JALPAC project
- 12:30pm-2:00pm
-
A multi-site survey of Parkinson’s disease deep brain stimulation center best practice: moving toward a standard of care for DBS
- 12:30pm-2:00pm
-
A novel interdisciplinary palliative care clinic for advanced Parkinson’s disease and Parkinsonian syndromes
- 12:30pm-2:00pm
-
A pilot study of horizontal current steering with chronically implanted segmented electrodes for STN-DBS in Parkinson’s disease
- 12:30pm-2:00pm
-
A polysomnography study of REM sleep without atonia and REM sleep behavior disorder in MSA and PD
- 12:30pm-2:00pm
-
A prospective study of patients’ expectations in subthalamic nucleus deep brain stimulation for Parkinson’s disease
- 12:30pm-2:00pm
-
A study to assess the quality of life and strain in caregivers of people with Parkinson’s disease in India
- 12:30pm-2:00pm
-
Accuracy of intraoperative CT during DBS procedures: Comparison with postoperative MRI
- 12:30pm-2:00pm
-
An elderly patient presenting as pure akinesia with gait freezing (PAGF): Idiopathic aqueductal stenosis-associated hydrocephalus
- 12:30pm-2:00pm
-
An international, randomized, sham controlled trial of focused ultrasound thalamotomy for essential tremor
- 12:30pm-2:00pm
-
An investigation of Parkinson’s disease patients’ desired control over the DBS stimulator
- 12:30pm-2:00pm
-
Anosmia predicts development of more severe motor symptoms including freezing of gait and impaired balance at 2 year follow-up in PD
- 12:30pm-2:00pm
-
Anxiety in patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Anxiolytic-like activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) in rodent models of anxiety
- 12:30pm-2:00pm
-
Apathy and striatal dopamine defects in non-demented patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Appendicitis and risk of Parkinson’s disease: A Danish nationwide population-based cohort study
- 12:30pm-2:00pm
-
Application and correlates of the PSP quality of life scale
- 12:30pm-2:00pm
-
Application of Parkinson’s well-being map to assess impairment of digestive system in patients of Tomsk region, Russia
- 12:30pm-2:00pm
-
Application of the MDS research criteria for prodromal Parkinson’s disease to the longitudinal population-based Bruneck study cohort
- 12:30pm-2:00pm
-
Are inflammatory bowel disease and/or treatment with aminosalicylates protective factors against Parkinson’s disease?
- 12:30pm-2:00pm
-
Are people with Parkinson’s disease living in care homes in the UK underserved? Identifying models of care and barriers to care access
- 12:30pm-2:00pm
-
Articulography reveals disturbed speech motor control in ET patients treated with VIM-DBS
- 12:30pm-2:00pm
-
Assessing the impact of PD motor symptom states on quality of life in patients with advanced Parkinson’s disease
- 12:30pm-2:00pm
-
Assessment of gait dysfunction in patients with Parkinson’s disease and REM behavioral disorder
- 12:30pm-2:00pm
-
Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Association of UV radiation with Parkinson’s disease incidence: A nationwide French ecologic study
- 12:30pm-2:00pm
-
Atypical parkinsonism in C9orf72 expansions: A case report and systematic review of 45 cases from the literature
- 12:30pm-2:00pm
-
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy
- 12:30pm-2:00pm
-
Autonomic failure and circadian rhythm of arterial blood pressure in IDIOPATHIC REM behaviour disorders and Parkinson’s disease
- 12:30pm-2:00pm
-
Awareness and perception of gastrointestinal symptoms in Parkinson´s disease: A survey of patients and caregiving relatives
- 12:30pm-2:00pm
-
Bacterial biofilm formation on neurostimulation systems
- 12:30pm-2:00pm
-
Barriers to providing quality care for people with Parkinson’s living in care homes in the UK: The role of staff training
- 12:30pm-2:00pm
-
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease. PPMI cohort
- 12:30pm-2:00pm
-
Bradykinesia of external urethral sphincter in a Patient with Parkinson’s disease: Case report
- 12:30pm-2:00pm
-
Brain structural abnormalities in multiple system atrophy patients with cognitive impairment
- 12:30pm-2:00pm
-
Broadening the evaluative scope of quality of life in Parkinson’s: Testing the construct validity of the ICECAP-O instrument
- 12:30pm-2:00pm
-
Can a leopard changes its spots? How impulse control disorder affects subthalamic stimulation paradigm
- 12:30pm-2:00pm
-
Can deep brain stimulation implantation cause multiple system atrophy? A retrospective review of MSA patients
- 12:30pm-2:00pm
-
Can intraoperative clinical testing really predict the effects of deep brain stimulation in the subthalamic nucleus?
- 12:30pm-2:00pm
-
Can stimulation of deep brain tissue improve the expression of the mouth in Parkinson’s disease patients?
- 12:30pm-2:00pm
-
Cardiometabolic syndrome and risk of Parkinson’s disease: A case-control study in Mexican population
- 12:30pm-2:00pm
-
Cerebral vasoreactivity in Parkinson’s disease and multiple system atrophy: A pilot study
- 12:30pm-2:00pm
-
Changes in mood and behavior following DBS – Measurement by self-reported questionaires
- 12:30pm-2:00pm
-
Characteristics of patients initiating droxidopa for the treatment of neurogenic orthostatic hypotension (nOH)
- 12:30pm-2:00pm
-
Characterization of sleep disturbances in a prospective population-based cohort to investigate Parkinson’s disease
- 12:30pm-2:00pm
-
Chin EMG variance and dream-enactment behavior during polysomnography in Parkinson’s disease
- 12:30pm-2:00pm
-
Chronic acquired hepatocerebral degeneration: Efficacy of liver transplatation in 10 patients
- 12:30pm-2:00pm
-
Chronic directional subthalamic nucleus deep brain stimulation in Parkinson’s disease – A pilot study
- 12:30pm-2:00pm
-
Chronic levodopa treatment accelerates the disorders of circadian rhythm in 6-OHDA induced Parkinson’s disease model
- 12:30pm-2:00pm
-
Clinical and biological predictors of excessive daytime sleepiness in early Parkinson’s disease
- 12:30pm-2:00pm
-
Clinical and polysomnographic features correlates to sleep-disordered breathing in multiple system atrophy
- 12:30pm-2:00pm
-
Clinical efficacy of istradefylline on lower urinary tract symptoms in Parkinson’s disease: A prospective study
- 12:30pm-2:00pm
-
Clinical features of Parkinson’s disease patients developing stridor with acute respiratory failure
- 12:30pm-2:00pm
-
Clinical outcome of constant current deep brain stimulation in patients with medication-refractory essential tremor
- 12:30pm-2:00pm
-
Clinical outcome of subthalamic deep brain stimulation in Parkinson’s disease – The Helsinki experience
- 12:30pm-2:00pm
-
Clinical predictors of progressive supranuclear palsy (PSP) pathology in PSP syndrome
- 12:30pm-2:00pm
-
Clinical profile of Parkinson’s disease at the neurology department of Point G Teaching Hospital
- 12:30pm-2:00pm
-
Clinicopathological characteristics of co-existant Parkinson’s disease and corticobasal degeneration: A case study
- 12:30pm-2:00pm
-
Cognitive change following deep brain stimulation in patients with movement disorders
- 12:30pm-2:00pm
-
Cognitive impairment in Parkinson’s disease
- 12:30pm-2:00pm
-
Cognitive impairment in patients with progressive supranuclear palsy and multiple system atrophy
- 12:30pm-2:00pm
-
Cognitive outcome in the patients with Parkinson’s disease one year after subthalamic implants in Taiwan
- 12:30pm-2:00pm
-
Cognitive profile in the Parkinsonian variant of multiple system atrophy: Findings from a Tunisian cohort
- 12:30pm-2:00pm
-
Comorbidity and Parkinson’s disease phenotype, dopaminergic function and CSF biomarkers
- 12:30pm-2:00pm
-
Comparative analysis of freezing of gait in distinct parkinsonism types by diffusion tensor imagining and cognitive profiles
- 12:30pm-2:00pm
-
Comparative gait analysis of patients with vascular parkinsonism and idiopathic Parkinson’s disease
- 12:30pm-2:00pm
-
Comparing psychosocial risk factors in patients with functional movement disorders and patients with psychogenic non-epileptic seizures
- 12:30pm-2:00pm
-
Comparing the characteristics of patients with Parkinson’s disease speech with and without deep brain stimulation
- 12:30pm-2:00pm
-
Comparison of clinically derived and model based programming parameters of subthalamic nucleus stimulation in Parkinson’s disease
- 12:30pm-2:00pm
-
Comparison of four DBS lead designs under voltage and current operating modes based on patient specific simulations
- 12:30pm-2:00pm
-
Composite autonomic symptom scale-31 (COMPASS-31) is useful for evaluation of autonomic dysfunction in patients with parkinsonism
- 12:30pm-2:00pm
-
Comprehensive motor and non-motor staging system in Parkinson’s disease: Results from a global cross-sectional study
- 12:30pm-2:00pm
-
Constant-current stimulation in Parkinson’s disease patients
- 12:30pm-2:00pm
-
Consumption of Yerba Mate (Ilex Paraguariensis) in Parkinson’s disease patients from Uruguay
- 12:30pm-2:00pm
-
Correlations among motor, cognitive, and neuropsychiatric symptoms in Parkinson’s disease without dementia
- 12:30pm-2:00pm
-
Cortical and subcortical contribution in the production of reaching movements in Parkinson’s disease
- 12:30pm-2:00pm
-
Could smell test differ from scans without evidence of dopaminergic deficit and Parkinson’s disease?
- 12:30pm-2:00pm
-
Creative thinking and parkinsonism: Preliminary clinical data on the role of frontal area
- 12:30pm-2:00pm
-
Dat-SPECT in multiple system atrophy (MSA)
- 12:30pm-2:00pm
-
DBS of the STN in 44 patients with Parkinson’s disease – Radiological and clinical outcome
- 12:30pm-2:00pm
-
DBS programming requirements and longevity
- 12:30pm-2:00pm
-
DBS related on-state freezing of gait – A case series
- 12:30pm-2:00pm
-
DBS targeting: Validation of 3T MR image guided targeting using post-mortem 17T MR microscopy
- 12:30pm-2:00pm
-
Deceleration capacity of heart rate indicates autonomic dysfunction in patients with PSP
- 12:30pm-2:00pm
-
Deep brain stimulation effect on the quality of life of individuals with Parkinson’s disease
- 12:30pm-2:00pm
-
Deep brain stimulation of the globus pallidus interna improves performance in complex oculomotor tasks
- 12:30pm-2:00pm
-
Deep brain stimulation outcomes for dystonia in adult and pediatric patients at Gillette Children’s Specialty Healthcare
- 12:30pm-2:00pm
-
Dementia in adult type 2 diabetes patients – An analysis from the multicenter German/Austrian diabetes patient follow-up registry DPV
- 12:30pm-2:00pm
-
Dementia in Parkinson’s disease is associated with increased diffusivity in amygdala and external capsule
- 12:30pm-2:00pm
-
Demographic feature and clinical characteristic of patients with Parkinson’s disease in Isfahan, Iran
- 12:30pm-2:00pm
-
Depression and anxiety in Parkinson’s disease with rapid eye movement sleep behavior disorder
- 12:30pm-2:00pm
-
Depression, anxiety, and apathy in Parkinson’s disease: Insights from neuroimaging studies
- 12:30pm-2:00pm
-
Detrusor overactivity is associated with frontal dysfunction in patients with Parkinson’s disease?
- 12:30pm-2:00pm
-
Developing palliative care clinics for patients with advanced Parkinson’s disease: Practical approaches, challenges, and experiences
- 12:30pm-2:00pm
-
Development and external validation of a prognostic model of mortality in Parkinson’s disease
- 12:30pm-2:00pm
-
Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson’s disease diagnosis
- 12:30pm-2:00pm
-
Difference between physiologically defined subthalamic nucleus target and final lead placement: Influence in clinical outcome
- 12:30pm-2:00pm
-
Disease stage classification of the cerebellar variant of multiple system atrophy based on voxel-based morphometry
- 12:30pm-2:00pm
-
Distribution of oscillatory activities in MRI confirmed subthalamic nucleus subregions
- 12:30pm-2:00pm
-
Does body mass index influence outcome of deep brain stimulation in Parkinson’s patients?
- 12:30pm-2:00pm
-
Does GPi-DBS help non motor symptoms in cervical dystonia patients? A retrospective study of 17 patients
- 12:30pm-2:00pm
-
Does link between fatigue syndrome and camptocormia in patients with Parkinson’s disease exist?
- 12:30pm-2:00pm
-
Dophaminergic therapy and its influence on the olfactory function of patients with Parkinson’s disease
- 12:30pm-2:00pm
-
DTI tractographic correlates of weight gain in Parkinson’s disease patients after STN DBS
- 12:30pm-2:00pm
-
Dystonia in a medieval scribe: Analysis of Bernard Blancard’s handwriting over four decades
- 12:30pm-2:00pm
-
E-counselling to movement disorder callers in Africa
- 12:30pm-2:00pm
-
Effect of bilateral subthalamic nuclei deep brain stimulation on impulse control disorders in PD
- 12:30pm-2:00pm
-
Effect of frequency modulation on freezing of gait in PD patients after bilateral STN DBS
- 12:30pm-2:00pm
-
Effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson’s disease: 7- year follow-up
- 12:30pm-2:00pm
-
Effectiveness of occupational therapy multi-domain group therapy program for Parkinson’s disease
- 12:30pm-2:00pm
-
Effects of subthalamic deep brain stimulation in motor and nonmotor function in Parkinson’s disease patients with parkin mutation
- 12:30pm-2:00pm
-
Efficacy of the bilateral subthalamic stimulation in Parkinson’s disease, results from the Neuromodulation Centre in Budapest
- 12:30pm-2:00pm
-
Electric stimulation of the nucleus subthalamicus is able to modulate prepulse inhibition. A pilot study in Parkinson´s disease
- 12:30pm-2:00pm
-
Electrophysiological activity of anatomically identified STN subterritories in Parkinson’s disease
- 12:30pm-2:00pm
-
Emotional valence and arousal ratings from rewarding and fearful stimuli are not influenced by levodopa in Parkinson’s disease
- 12:30pm-2:00pm
-
Ethnic differences in rates of Parkinson’s in New Zealand: A nation-wide prevalence and incidence study
- 12:30pm-2:00pm
-
Evaluation of stigmatization and quality of life before and after botulinum toxin treatment in hemifacial spasm
- 12:30pm-2:00pm
-
Evaluation of the [ 99mTc] – TRODAT- 1 SPECT in the diagnosis of Parkinson’s disease and other movement disorders
- 12:30pm-2:00pm
-
Evaluation of the accuracy of stereotactic DBS electrode implantation by post-operative image fusion
- 12:30pm-2:00pm
-
Exploring association of GBA variants with pre-diagnostic features of PD in the PREDICT-PD cohort: A nested case-control study
- 12:30pm-2:00pm
-
Face and color recognition after subthalamic nucleus stimulation in Parkinson’s disease
- 12:30pm-2:00pm
-
Feasibility and preliminary outcomes of an interdisciplinary home visit program for patients with advanced Parkinson’s disease
- 12:30pm-2:00pm
-
Finger tapping distance in idiopathic normal pressure hydrocephalus changes in parallel with frontal lobe function
- 12:30pm-2:00pm
-
Focusing precision and lesion size in cerebello-thalamo-tractotomy by MR imaging-guided high intensity focused ultrasound (MRgFUS)
- 12:30pm-2:00pm
-
Frequency and characteristics of diplopia in non-demented patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Functional motor outcomes after globus pallidus internus deep brain stimulation in Huntington´s disease – A case report
- 12:30pm-2:00pm
-
Fundamental differences in Parkinsonian rat limbic regions contribute to anxious behavior and diminished responsiveness to diazepam
- 12:30pm-2:00pm
-
Gastrointestinal non-motor symptoms in PD: Correlation between objective markers and subjective symptoms
- 12:30pm-2:00pm
-
Gender differences in heart rate variability among patients affected by Parkinson’s disease
- 12:30pm-2:00pm
-
Gender effect on non-motor symptoms in Parkinson’s disease: Are men more at risk for most of them?
- 12:30pm-2:00pm
-
Glucagon-like peptide 1 analogues for treating multiple system atrophy: A translational study
- 12:30pm-2:00pm
-
Greater incidence of depressive symptoms in atypical parkinsonism: Importance of early screening
- 12:30pm-2:00pm
-
Group meetings for newly diagnosed Parkinson’s disease patients and their spouses: A preliminary experience
- 12:30pm-2:00pm
-
Hand skin temperature and its response to cooling in clinical differentiation of multiple system atrophy and Parkinson’s disease
- 12:30pm-2:00pm
-
Head and trunk control during stair ascent and descent in people with Parkinson’s disease
- 12:30pm-2:00pm
-
Health related quality of life in patient with Parkinson’s disease using deep brain stimulators (DBS)- A cross sectional study
- 12:30pm-2:00pm
-
Health-related quality of life of multisystem atrophy and progressive supranuclear palsy patients
- 12:30pm-2:00pm
-
High frequency of mutations in the glucocerebrosidase (GBA) gene among Ashkenazi Jews with dementia with Lewy bodies
- 12:30pm-2:00pm
-
How do patients experience deep brain stimulation surgery: A prospective patient satisfaction survey
- 12:30pm-2:00pm
-
Hyposmia as a predictor of non-motor symptom in patients with de novo Parkinson’s disease
- 12:30pm-2:00pm
-
Hypothalamic alpha-synuclein pathology and its relation to non-motor symptoms and disease progression in Parkinson’s disease
- 12:30pm-2:00pm
-
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson’s disease
- 12:30pm-2:00pm
-
Identification of barriers preventing disclosure of non-motor symptoms in Parkinson’s patients to healthcare providers
- 12:30pm-2:00pm
-
Identification of premotor Parkinson’s disease
- 12:30pm-2:00pm
-
Identification of unique metabolite signatures in post-mortem DBS human tissue using LC-HRMS
- 12:30pm-2:00pm
-
Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review
- 12:30pm-2:00pm
-
Idiopathic Parkinson’s disease presenting with dysphagia 15 years before PD diagnosis
- 12:30pm-2:00pm
-
Imaging-based differential diagnosis between multiple system atrophy and Parkinson’s disease
- 12:30pm-2:00pm
-
Impact of autonomic dysfunction on disease progression and survival in Parkinson’s disease
- 12:30pm-2:00pm
-
Impact of cardiovascular risk factors in the evolution and treatment of Parkinson’s disease in Mexican population
- 12:30pm-2:00pm
-
Impact of comorbidities and compliance initiatives in management of patients with early Parkinson’s disease
- 12:30pm-2:00pm
-
Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson’s patients
- 12:30pm-2:00pm
-
Impact of neurogenic orthostatic hypotension on healthcare utilization and costs associated with falls in Parkinson’s disease
- 12:30pm-2:00pm
-
Impact of pre- and postdiagnosis physical activity on the progression of Parkinson’s disease
- 12:30pm-2:00pm
-
Impact of self-efficacy education on physical and psychosocial functioning in newly-diagnosed Parkinson patients
- 12:30pm-2:00pm
-
Impact of subclinical apathy prior to deep brain stimulation on the quality of life of patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Impact of the combined depletion of monoamines on the effectiveness of deep brain stimulation of the subthalamic nucleus
- 12:30pm-2:00pm
-
Impaired color discrimination selectively associates with postural instability and gait difficulties in Parkinson’s disease
- 12:30pm-2:00pm
-
Implications of direct and indirect costs in health-related quality of life in Parkinson’s disease: A cross-sectional study in Mexico
- 12:30pm-2:00pm
-
Improvement of impulse control disorder in Parkinson’s disease patients treated with subthalamic nucleus stimulation
- 12:30pm-2:00pm
-
Improving parkinsonism in DBS poor-responders by surgical lead revision of subthalamic electrodes
- 12:30pm-2:00pm
-
In vivo validation of a new wireless portable stimulator for chronic deep brain stimulation in freely moving rats
- 12:30pm-2:00pm
-
Incidence and characteristics of gait dysfunction after subthalamic nucleus deep brain stimulation
- 12:30pm-2:00pm
-
Increased access to training in a Parkinson-specific rehabilitation approach through online learning
- 12:30pm-2:00pm
-
Influence of motor manifestation and onset’s side on the spectrum of non-motor symptoms in patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Influence of onset age on the progression of non-motor symptoms in Parkinson’s disease: A prospective study from Southwest China
- 12:30pm-2:00pm
-
Initial clinical description of progressive supranuclear palsy in the Luxembourg Parkinson’s study
- 12:30pm-2:00pm
-
Introducing the 2nd edition of the occupational therapy for people with Parkinson’s: Best practice guidance
- 12:30pm-2:00pm
-
Is continuous twenty four hour blood pressure monitoring a suitable tool in evaluating sleep disturbances in Parkinson’s disease?
- 12:30pm-2:00pm
-
Is inter-limb coupling modified by subthalamic deep brain stimulation and dopaminergic medication in Parkinson’s disease?
- 12:30pm-2:00pm
-
Is the PPN a valuable target for deep brain stimulation in treatment of Parkinsonian disorders? Experience of a patient’s series
- 12:30pm-2:00pm
-
Italian olfactory identification test (IOIT) scores correlates with clinical features in Parkinson’s disease
- 12:30pm-2:00pm
-
J-FIRST: First-in-Japan observational study of Parkinson’s disease treatments and nonmotor symptoms
- 12:30pm-2:00pm
-
Jan Evangelista Purkinje: Contributions to study of anatomy and physiology of movement disorders
- 12:30pm-2:00pm
-
Jaw opening dystonia and blepharospasm following bilateral VIM DBS for postural and action dystonic tremor
- 12:30pm-2:00pm
-
Lead angle matters: Side effects of deep brain stimulation improved with adjustment of lead angle
- 12:30pm-2:00pm
-
Leukocyte perturbations suggest immune dysregulation in progressive supranuclear palsy
- 12:30pm-2:00pm
-
Longitudinal changes of speech and voice disorders following subthalamic stimulation in Parkinson’s disease patients
- 12:30pm-2:00pm
-
Longitudinal evolution of possible REM sleep behavior disorder in early Parkinson’s disease
- 12:30pm-2:00pm
-
Loss of FBXO7 (PARK15) leads to disturbances in proteasomal function and models parkinsonism-like and pyramidal symptoms in mice
- 12:30pm-2:00pm
-
Magnetic resonance characteristic of Parkinson’s disease based on the presence of cognitive impairment
- 12:30pm-2:00pm
-
Meaningful life attitudes support positive coping in patients with idiopathic Parkinson’s disease
- 12:30pm-2:00pm
-
Measuring interdependence of the health status of people with Parkinson’s disease and their spouses
- 12:30pm-2:00pm
-
Medication errors: The role of the nurse in an interdisciplinary home visit program for advanced Parkinson’s disease patients
- 12:30pm-2:00pm
-
Mild Parkinsonian signs and TIA/stroke
- 12:30pm-2:00pm
-
Minimal impact of “interleaving” on neuromodulation device battery drain when interleave frequency is halved
- 12:30pm-2:00pm
-
Modeling trajectories of brain damage in progressive supranuclear palsy: A longitudinal multimodal MRI study
- 12:30pm-2:00pm
-
Modulation and mechanism for the neuroprotective effects of 17-beta-estradiol: Relevance to depressive symptoms in Parkinson’s disease
- 12:30pm-2:00pm
-
Morbidity and comorbidity of deep brain stimulation for Parkinson’s disease – A thirteen-years retrospective cohort study
- 12:30pm-2:00pm
-
Mortality after deep brain stimulation surgery for patients with advanced Parkinson’s disease
- 12:30pm-2:00pm
-
Motor and non-motor symptoms in Parkinson’s disease: Correlation and impact on quality of life and activities of daily living
- 12:30pm-2:00pm
-
Motor features and response to levodopa in Parkinson’s disease with normal olfactory function
- 12:30pm-2:00pm
-
Motor rigidity selectively associates with impaired odor identification in Parkinson’s disease
- 12:30pm-2:00pm
-
Movement disorders (Parkinson’s disease) in Uzbekistan: Epidemiologic, clinical and therapeutic aspects
- 12:30pm-2:00pm
-
Movement disorders in patients with Japanese encephalitis: Experience in a tertiary care hospital in north eastern region of India
- 12:30pm-2:00pm
-
MR-guided high intensity focused ultrasound in Parkinson’s disease: A series of 5 cases
- 12:30pm-2:00pm
-
Multiple-source current steering in bilateral subthalamic nucleus deep brain stimulation for Parkinson’s disease: Our experience
- 12:30pm-2:00pm
-
Muscle ceroid-lipofuscine-like deposits in a patient with FTD due to a progranulin mutation
- 12:30pm-2:00pm
-
Neurocognitive domains of impulsivity in Parkinson’s disease (PD) and the effects of dopaminergic replacement therapy (DRT)
- 12:30pm-2:00pm
-
Nighttime sleep problems in patients with Parkinson’s disease: Risk factors and longitudinal associations
- 12:30pm-2:00pm
-
Non-contact boxing in Parkinson’s disease
- 12:30pm-2:00pm
-
Non-motor outcomes of subthalamic stimulation in Parkinson’s disease depend on the location of active contacts
- 12:30pm-2:00pm
-
Non-motor symptoms (NMS) as a determinant of caregiver burden in a cohort of older patients with Parkinson’s disease (PD)
- 12:30pm-2:00pm
-
Non-motor symptoms in a PPMI cohort of p.A53T α-synuclein mutation-related and sporadic Parkinson’s disease patients
- 12:30pm-2:00pm
-
Non-motor symptoms in PD candidates for DBS treatment
- 12:30pm-2:00pm
-
Non-motor symptoms in progressive supranuclear palsy
- 12:30pm-2:00pm
-
Non-motor symptoms trajectory in Parkinson’s disease: Magnitude and importance of the change
- 12:30pm-2:00pm
-
Nutritional status and quality of life in patients with Parkinson’s disease in a tertiary hospital in Northeast Mexico
- 12:30pm-2:00pm
-
Objectives of the MDS rare movement disorders study group
- 12:30pm-2:00pm
-
Objectivisation of postural disorders in patients with Parkinson’s disease during the screening stage for DBS
- 12:30pm-2:00pm
-
Olfactory deficit characterization in Parkinson’s disease
- 12:30pm-2:00pm
-
Olfactory testing in differential diagnosis of atypical essential tremor and tremor-dominant Parkinson’s disease
- 12:30pm-2:00pm
-
Orthostatic intolerance and falls in Parkinson’s disease
- 12:30pm-2:00pm
-
P100 latency of pattern reversal visual evoked potential and visual hallucination in Parkinson’s disease
- 12:30pm-2:00pm
-
Parkinson’s disease and the frequent reasons for emergency admission in Metropolitan Medical Center; a 2 year retrospective study
- 12:30pm-2:00pm
-
Parkinson’s disease is characterised by differences in lower limb joint kinetics during stair ascent and descent
- 12:30pm-2:00pm
-
Parkinson’s in an aging population: Implications from a nation-wide prevalence and incidence study in New Zealand
- 12:30pm-2:00pm
-
Parkinson’s syndrome as possible manifestation of lamina quadrigemina tumor or inflammation
- 12:30pm-2:00pm
-
Parkinsonian syndrome prevalence in the world
- 12:30pm-2:00pm
-
Parkinsonism in patients with CADASIL
- 12:30pm-2:00pm
-
Parkinsonism risk factors in Salt Lake City, Utah
- 12:30pm-2:00pm
-
Patient-centered outcomes of DBS in Parkinson’s disease
- 12:30pm-2:00pm
-
Patients’ employment status and quality of life affect caregivers burden in Parkinson’s disease in Singapore
- 12:30pm-2:00pm
-
Phenotypic differences between African American and Caucasian Parkinson’s disease patients
- 12:30pm-2:00pm
-
Pisa syndrome in Parkinson’s disease effectively treated with subthalmic deep brain stimulation: Case report
- 12:30pm-2:00pm
-
Predicting poor functional outcome in Parkinson’s disease
- 12:30pm-2:00pm
-
Preliminary results for a study on quality of life in Huntington’s disease patients and their caregivers in Peru
- 12:30pm-2:00pm
-
Preliminary results of a cross-linguistic comparison on dysarthria in Parkinson’s disease
- 12:30pm-2:00pm
-
Premotor symptoms as prognostic indicators of Parkinson’s disease: A nationwide population-based and case-control study
- 12:30pm-2:00pm
-
Prevalence and characterisation of vocal fold motion impairment (VFMI) in patients with multiple system atrophy
- 12:30pm-2:00pm
-
Prevalence and risk factors of orthostatic hypotension in Thai Parkinson’s disease patients
- 12:30pm-2:00pm
-
Prevalence of hemifacial spasm in Northern Cyprus
- 12:30pm-2:00pm
-
Prevalence of Parkinson’s disease and myotonic dystrophy in the nomadic population: Mongolian study
- 12:30pm-2:00pm
-
Prevalence of Parkinson’s disease in Ukraine
- 12:30pm-2:00pm
-
Prodromal Parkinson’s disease in Argentinean patients with Gaucher disease type 1: Preliminary report
- 12:30pm-2:00pm
-
Progression of microglial activation and neuroinflammatory responses in a transgenic mouse model of multiple system atrophy
- 12:30pm-2:00pm
-
Progressive supranuclear palsy as a manifestation of the second stage of CADASIL syndrome
- 12:30pm-2:00pm
-
Promoting optimal physiotherapy practice worldwide: Role of the Association of Physiotherapists in Parkinson’s disease Europe (APPDE)
- 12:30pm-2:00pm
-
PROSPECT: A UK-based longitudinal observational study of PSP, CBD, MSA and atypical parkinsonism syndromes
- 12:30pm-2:00pm
-
Pshychoeducational interventions for demented patients with parkinsonism and their families
- 12:30pm-2:00pm
-
PSP and HIV: Causality or coincidence?
- 12:30pm-2:00pm
-
Quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease
- 12:30pm-2:00pm
-
Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment
- 12:30pm-2:00pm
-
Quality of life and living with Parkinson’s in Ireland
- 12:30pm-2:00pm
-
Quantification of tremor and rigidity during deep brain stimulation surgery for Parkison’s disease
- 12:30pm-2:00pm
-
Quantitative MRI measurement of regional cerebellar involvement in patients with progressive supranuclear palsy
- 12:30pm-2:00pm
-
RBD increase non-motor symptom in Parkinson’s disease
- 12:30pm-2:00pm
-
Real-world safety of deep brain stimulation in patients with ≤7.5 years between disease onset and device implant
- 12:30pm-2:00pm
-
Recharge frequency is not driven by therapy power usage in patients implanted with rechargeable deep brain stimulation systems
- 12:30pm-2:00pm
-
Rechargeable pacemaker technology in deep brain stimulation: A step forward, but nor for everyone
- 12:30pm-2:00pm
-
Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy
- 12:30pm-2:00pm
-
Rehabilitation of dysphagia in Parkinson’s disease: Effect of chin-down postural maneuver
- 12:30pm-2:00pm
-
Relationship between cognitive functions and striatal 123I-FP-CIT uptake in Parkinson’s disease
- 12:30pm-2:00pm
-
Results from a double-blind trial of pallidal DBS for Tourette’s syndrome: Are there any predictors of surgery outcome?
- 12:30pm-2:00pm
-
Retinal nerve fiber layer thinning: A window into rapid eye movement sleep behavior disorders in Parkinson’s disease
- 12:30pm-2:00pm
-
Risks and predictive factors for pneumonia amongst Parkinson’s disease patients with dysphagia
- 12:30pm-2:00pm
-
Role of contact polarity on therapeutic impedances at two deep brain stimulation (DBS) targets
- 12:30pm-2:00pm
-
Rotenone and Parkinson’s disease (PD): Effect modification by membrane transporter variants
- 12:30pm-2:00pm
-
Safety of deep brain stimulation for movement disorders: A single-centre long-term standardized recording and analysis
- 12:30pm-2:00pm
-
Serum brain-derived neurotrophic factor as an indication of disease state in parkinsonism and RBD
- 12:30pm-2:00pm
-
Single versus multiple microelectrode recordings (MER) in STN-DBS-surgery for PD: A randomized double-blind controlled trial
- 12:30pm-2:00pm
-
Sleep disordered breathing in patients of Parkinson’s disease with REM sleep behavior disorder
- 12:30pm-2:00pm
-
Sleep disorders in progressive supranuclear palsy
- 12:30pm-2:00pm
-
Speech evaluation in Parkinson’s disease using a transcribed version of the Frenchay dysarthria assessment
- 12:30pm-2:00pm
-
Spinal cord stimulation improves freezing of gait in Parkinson’s disease in chronic implanted stn-dbs patients: A case report
- 12:30pm-2:00pm
-
Stimulation of the globus pallidus internus in the treatment of Parkinson’s disease: Long-term results of a monocentric follow-up
- 12:30pm-2:00pm
-
Strengths and weaknesses of patient-reported outcomes following DBS surgery: Comparing clinician, patient, and caregiver assessments
- 12:30pm-2:00pm
-
Subjective report does not predict objective swallow impairment in atypical Parkinsonian syndromes
- 12:30pm-2:00pm
-
Successful DBS: Doctors happy, patients not – Why?
- 12:30pm-2:00pm
-
Surgical replacement of implantable pulse generators in deep brain stimulation: Adverse events and risk factors in a multicenter cohort
- 12:30pm-2:00pm
-
Survey of prodromal symptoms of Parkinson’s disease in Japan
- 12:30pm-2:00pm
-
Survival and risk of mortality of synucleinopathies: A 15 years population-based study (1991 – 2005)
- 12:30pm-2:00pm
-
Systematic literature review of droxidopa in clinical trials for neurogenic orthostatic hypotension (nOH) in parkinsonism
- 12:30pm-2:00pm
-
Targeting TLR4 for disease modification in multiple system atrophy: Experimental evidence
- 12:30pm-2:00pm
-
Thalamic deep brain stimulation for cerebellar outflow tremor and midbrain tremor: a case series
- 12:30pm-2:00pm
-
Thalamic-subthalamic deep brain stimulation for refractory orthostatic tremor: A report of 3 cases
- 12:30pm-2:00pm
-
The association between objectively measured physical activity and health-related-quality of life in people with Parkinson’s disease
- 12:30pm-2:00pm
-
The Catalan multiple system atrophy-registry (CMSAR)
- 12:30pm-2:00pm
-
The changing profile of informal carers for people with Parkinson’s with disease progression
- 12:30pm-2:00pm
-
The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson’s disease
- 12:30pm-2:00pm
-
The effect of a structured medication review on quality of life in patients with Parkinson’s disease. An interim analysis
- 12:30pm-2:00pm
-
The effect of short pulse width neurostimulation in GPi-DBS
- 12:30pm-2:00pm
-
The effects of dysphagia course for speech & language pathologist in Israel on clinical-related knowledge and confidence
- 12:30pm-2:00pm
-
The effects of fluvoxamine maleate in a post-natal stress rat model of neurodegeneration
- 12:30pm-2:00pm
-
The evolution of REM sleep behavior disorder in Parkinson’s disease: The DeNoPa cohort at 2-year follow-up
- 12:30pm-2:00pm
-
The impact of a movement disorders specialist on resident knowledge, as measured by the resident in-service training examination (RITE)
- 12:30pm-2:00pm
-
The initial motor symptom of Parkinson’s disease in relation to age at onset and gender: A Sri Lankan perspective
- 12:30pm-2:00pm
-
The National Parkinson Foundation mentoring and networking program: Phase I the process
- 12:30pm-2:00pm
-
The prevalence of constipation and irritable bowel syndrome in Parkinson’s disease patients according to Rome III diagnostic criteria
- 12:30pm-2:00pm
-
The prevalence of gastrointestinal disorders and non-motor symptoms in a cohort of patients with Parkinson’s disease
- 12:30pm-2:00pm
-
The relation between dream content and non-motor symptoms in Parkinson’s disease and idiopathic REM sleep behavior disorder
- 12:30pm-2:00pm
-
The relationship between body composition and postural instability in idiopathic Parkinson’s disease
- 12:30pm-2:00pm
-
The relationship between the cognitive phenotype and 5-HT2A receptor in PD with visual hallucinations
- 12:30pm-2:00pm
-
The role of diabetes mellitus and hyperglycemia in early de novo Parkinson’s disease patients
- 12:30pm-2:00pm
-
The score changes of clinical symptom assessment scales for multiple system atrophy in 2-3 years
- 12:30pm-2:00pm
-
The study of clinical outcome of deep brain stimulation for the idiopathic Parkinson’s disease at 6 months follow-up
- 12:30pm-2:00pm
-
The value of preference-based measures of quality of life in people with Parkinson’s: A systematic review
- 12:30pm-2:00pm
-
Theta burst repetitive transcranial magnetic stimulation in a case with cortical-basal ganglionic degeneration
- 12:30pm-2:00pm
-
Tourette syndrome treated by continuous electrical neuromodulation (DBS): Targeting the comorbidities?
- 12:30pm-2:00pm
-
Trajectories of prediagnostic functioning in Parkinson’s disease during 14 years before clinical onset
- 12:30pm-2:00pm
-
Transient mild hyperglycemia as diagnostic tool for idiopatic Parkinson’s disease triggered by psychoemotional stress
- 12:30pm-2:00pm
-
Transient, symptomatic, non-infectious hypodensity around deep brain stimulation electrode
- 12:30pm-2:00pm
-
Translation of the European physiotherapy guideline for Parkinson’s disease to Portuguese
- 12:30pm-2:00pm
-
Treating Parkinson’s 2015–A nationwide survey of treatment responses and complications in 1000 Irish patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Treatment of lipopolysaccharide-induced parkinsonism
- 12:30pm-2:00pm
-
Triple stimulation technique findings in patients with Parkinson’s disease and multiple system atrophy
- 12:30pm-2:00pm
-
Types of farming and prevalence and incidence of Parkinson’s disease: French nationwide study
- 12:30pm-2:00pm
-
Unawareness of causes of sudden deterioration in Parkinson’s patients in movement disorder clinic
- 12:30pm-2:00pm
-
Unilateral dual lead thalamic deep brain stimulation improves refractory essential tremor
- 12:30pm-2:00pm
-
Unilateral MR-guided high intensity focused ultrasound ablation of the cerebellothalamic tract in essential tremor
- 12:30pm-2:00pm
-
Unusual motor and non-motor symptoms and signs in the early stage of Parkinson´s disease
- 12:30pm-2:00pm
-
Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia
- 12:30pm-2:00pm
-
Usefulness of total neuropathy score revised as a screening tool of peripheral neuropathy in patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Validation study of Parkinson anxiety scale, Czech version
- 12:30pm-2:00pm
-
Valproate-induced reversible parkinsonism – A case series
- 12:30pm-2:00pm
-
Variability in the ideal target of GPi DBS for Parkinson’s disease requires advanced direct targeting for optimal results
- 12:30pm-2:00pm
-
Vocal fold augmentation in patients with Parkinson’s disease: A case series and review of the literature
- 12:30pm-2:00pm
-
Wearable sensors and decision algorithms for advanced therapy referral in Parkinson’s disease
- 12:30pm-2:00pm
-
When DBS can be of benefit in Huntington’s disease
- 12:30pm-2:00pm
-
Work-related stress and risk for Parkinson’s disease
- 12:30pm-2:00pm
-
Zolpidem ameliorates the freezing of gait in a patient with PAGF (pure akinesia with freezing of gait)-the possible neural mechanism
- 12:30pm-2:00pm
-
α-synuclein CSF levels correlate with urinary dysfunction in early de novo Parkinson’s disease patients
- 12:30pm-2:00pm
-
α-synuclein in peripheral organs decreases in Lewy body disease complicated by Alzheimer’s disease
- 12:30pm-2:00pm
-
"Are patients with familial ET distinct from those with sporadic ET? Insight from 250 patients"
- 12:30pm-2:00pm
-
DYT2 screening in early-onset isolated dystonia in Italy
- 12:30pm-2:00pm
-
A clinico-genetical study in a large cohort of patients with spastic paraplegia type 4 (SPG4)
- 12:30pm-2:00pm
-
A comparative study of clinical profile of patients of drug induced parkinsonism with idiopathic Parkinson’s disease
- 12:30pm-2:00pm
-
A comprehensive characterisation of the salivary proteome of patients with Parkinson’s disease
- 12:30pm-2:00pm
-
A descriptive study on the safety and feasibility of mesenchymal stem cell therapy for Parkinson’s disease: A case series
- 12:30pm-2:00pm
-
A homozygous loss-of-function mutation in DNAJA3 causes hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V)
- 12:30pm-2:00pm
-
A novel C. elegans model for identification of small molecules that target alpha-synuclein-mediated toxicity
- 12:30pm-2:00pm
-
A novel haplotype in LRRK2 is associated with risk for multiple system atrophy in the Korean population
- 12:30pm-2:00pm
-
A novel single molecule imaging approach to detect individual protein oligomers in CSF from patients with Parkinson’s disease (PD)
- 12:30pm-2:00pm
-
A peripheral pathway to restless legs syndrome? Clues from familial amyloid polyneuropathy
- 12:30pm-2:00pm
-
A randomized, double-blind, placebo-controlled trial of deutetrabenazine for the treatment of tardive dyskinesia (ARM-TD)
- 12:30pm-2:00pm
-
A survey of movement disorders in a large sample of patients treated with antipsychotic medication
- 12:30pm-2:00pm
-
A validation study of a smartphone-based finger tapping application for quantitative assessment of bradykinesia in Parkinson’s disease
- 12:30pm-2:00pm
-
A web resource on levodopa-induced dyskinesia (LID) genetics
- 12:30pm-2:00pm
-
Age associated effects of levodopa administration on striatal acetylcholinesterase activity
- 12:30pm-2:00pm
-
Alcohol-responsive action myoclonus of the leg in prostate cancer: A novel paraneoplastic syndrome
- 12:30pm-2:00pm
-
Alpha-synuclein – super-resolution microscopy reveals potential new role of alpha-synuclein at the pre-synapse
- 12:30pm-2:00pm
-
Alpha-synuclein in gastric and colonic mucosa in Parkinson’s disease: Limited role as a biomarker
- 12:30pm-2:00pm
-
Alpha-synuclein levels and dimerization in erythrocytes of Parkinson’s disease patients
- 12:30pm-2:00pm
-
Altered connectivity within the cerebello-thalamo-cortical network in essential tremor: A resting state fMRI study
- 12:30pm-2:00pm
-
Altered glutamate response and calcium dynamics in iPSC derived striatal neurons from XDP-patients
- 12:30pm-2:00pm
-
Alternating hemiplegia of childhood (AHC) as a new presentation of adenylate cyclase 5 (ADCY5)-mutation-associated disease
- 12:30pm-2:00pm
-
An exuberant cortical γb influences the unmasking and intensity of dyskinesia in 6-OHDA-treated freely-moving rats
- 12:30pm-2:00pm
-
An open label trial to test the modulation of cerebellar motor pathways in primary orthostatic tremor using rTMS and fMRI
- 12:30pm-2:00pm
-
An optimized formulation of velocity distribution in digital spiral analysis to differentiate essential tremor and Parkinson’s disease
- 12:30pm-2:00pm
-
Analysis of relationships between spinal deformity and walking ability in Parkinson’s disease patients
- 12:30pm-2:00pm
-
Analysis of temporal gait features extracted from accelerometer-based signals during ambulatory walking in Parkinson’s disease
- 12:30pm-2:00pm
-
Apocyanin ameliorates post-stroke movement disorder in rats: Possible role of neurochemical and inflammatory alterations
- 12:30pm-2:00pm
-
Assessment of Parkinson’s disease risk loci as DNA methylation quantitative trait loci
- 12:30pm-2:00pm
-
Association of four new candidate genetic variants with Parkinson’s disease in Han Chinese
- 12:30pm-2:00pm
-
Association of Parkinson’s disease severity and cortical and subcortical cognitive markers
- 12:30pm-2:00pm
-
Associations between cerebrospinal fluid proteins and cytokines in Parkinson’s disease
- 12:30pm-2:00pm
-
Augmentation and impulse control disorders in restless legs syndrome – Coexistence or association?
- 12:30pm-2:00pm
-
Beyond initial clinical phenotype of Madelung disease: Myoclonus, gait disorder and multisystem involvement led to genetic diagnosis
- 12:30pm-2:00pm
-
Bi-hemispheric phase synchronization in patients with Parkinson’s disease during stance, gait and upper limb motor tasks
- 12:30pm-2:00pm
-
Brain metabolic profile changes reflect subtle pathological alterations in different murine models of Parkinson’s disease
- 12:30pm-2:00pm
-
Can body worn cameras help us understand the complex relationship between physical activity and falls in people with Parkinson’s?
- 12:30pm-2:00pm
-
Carrier mediated delivery system bearing dopamine for effective management of parkinsonism
- 12:30pm-2:00pm
-
Cell-surface expression of dopamine transporter facilitates the uptake of α-synuclein
- 12:30pm-2:00pm
-
Cellular senescence induced by paraquat drives neuropathology associated with Parkinson’s disease
- 12:30pm-2:00pm
-
Cerebellar atrophy in Parkinson’s disease and its implication for network connectivity
- 12:30pm-2:00pm
-
Characterisation of the A30P mutation in alpha-synuclein gene in patient-derived cellular model of Parkinson’s disease
- 12:30pm-2:00pm
-
Characteristics of the interaction between different toxic aggregated species of alpha-synuclein and cell membrane
- 12:30pm-2:00pm
-
Characterization of striatal TH-immunoreactive cells in chronic and acute L-DOPA treatment in a mice model of Parkinson´s disease
- 12:30pm-2:00pm
-
Children with idiopathic tics reveal additional features of hyperkinetic movement disorders
- 12:30pm-2:00pm
-
Chorea – Ballism drug induced in replacement treatment with thyroid hormones – Case presentation
- 12:30pm-2:00pm
-
Ciprofloxacin as the cause of syndroma extrapiramidale
- 12:30pm-2:00pm
-
Circadian dysfunction in Parkinson’s disease: Effects on impaired gait initiation and locomotion
- 12:30pm-2:00pm
-
Clinical and genetic analyses in a cohort of the Taiwanese patients with apparently sporadic pure spastic paraplegia
- 12:30pm-2:00pm
-
Clinical and imaging deterioration of a mild case of Wilson’s disease after chelation therapy
- 12:30pm-2:00pm
-
Clinical and neuroimaging outcomes up to 18 years after fetal tissue transplant for Parkinson’s disease
- 12:30pm-2:00pm
-
Clinical exome sequencing – diagnostic yield in a sample of German patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Clinical phenotype of Parkinsonian patients with α-synuclein mutation: Our case report and review of the literature
- 12:30pm-2:00pm
-
Clinical presentations of 2 Parkin / lysosomal storage disorder heterozygotes with Parkinson’s disease
- 12:30pm-2:00pm
-
Coding and non-coding glucocerebrosidase variants have an impact on cognitive decline in Parkinson’s disease
- 12:30pm-2:00pm
-
Cognitive and depressive behavior changes in aged mice with heterozygous deletions of VMAT2 or of DAT
- 12:30pm-2:00pm
-
Comparing tremor- and non-tremor effects of ethanol in patients with essential tremor
- 12:30pm-2:00pm
-
Comparison of two protocols for neural induction and cultivation of iPSCs derived neural stem cells
- 12:30pm-2:00pm
-
Computational analysis of expression profiling data in a neuronal model of X-linked dystonia-parkinsonism
- 12:30pm-2:00pm
-
Constipation in early de novo Parkinson’s disease: Prevalence and correlates with clinical features, imaging and non-imaging biomarkers
- 12:30pm-2:00pm
-
Correlation between tremor severity of essential tremor and perpendicular displacement in digital spiral analysis
- 12:30pm-2:00pm
-
Cortical impairment as marker of dementia risk in probable REM sleep behavior disorder in Parkinson’s disease
- 12:30pm-2:00pm
-
Cortical role in the freezing of gait in Parkinson’s disease
- 12:30pm-2:00pm
-
De novo mutations in PDE10A cause childhood-onset chorea with bilateral striatal lesions
- 12:30pm-2:00pm
-
Defective ubiquitinated mitochondria accumulation in aged Parkinsonian LRRK2R1441G knockin mice
- 12:30pm-2:00pm
-
Deficiency of HGprt in Lesch-Nyhan disease is associated with abnormal dopaminergic neurodevelopment in vivo
- 12:30pm-2:00pm
-
Deletions at 22q11.2 in idiopathic Parkinson’s disease: A combined analysis of GWAS data
- 12:30pm-2:00pm
-
Depression and apathy in restless legs syndrome
- 12:30pm-2:00pm
-
Detection of leucine-rich repeat kinase 2 in human biofluids
- 12:30pm-2:00pm
-
Development of the UK hereditary spastic paraplegia registry: Analysis of SPAST patients reveals high rate of psychiatric comorbidities
- 12:30pm-2:00pm
-
Diagnostic sensitivity and remote monitoring of motor and non-motor dysfunction in Parkinson’s disease
- 12:30pm-2:00pm
-
Difference of REM sleep behavior disorder between the onset of before and after Parkinson’s disease
- 12:30pm-2:00pm
-
Differences between responders and non-responders of Istradefylline for the wearing off in Parkinson’s disease
- 12:30pm-2:00pm
-
Differences of gut bacterial community relate to pathology progress in Parkinson’s disease
- 12:30pm-2:00pm
-
Differentiated versus undifferentiated mesenchymal stem cell therapy in paraquat model of Parkinson’s disease
- 12:30pm-2:00pm
-
Diffusion tensor imaging (DTI) within the primate caudate nucleus marks dopaminergic (DA) and serotonergic (5-HT) lesions
- 12:30pm-2:00pm
-
Diffusion tensor imaging biomarkers of nigrostriatal neurodegeneration in early Parkinson’s disease
- 12:30pm-2:00pm
-
Digitizing tablet and Fahn-Tolosa-Marín tremor ratings have comparable minimum detectable change
- 12:30pm-2:00pm
-
Discrimination of Parkinson’s disease participants from healthy controls using telephone-quality voice recordings
- 12:30pm-2:00pm
-
Disruption of circadian rhythm function and anti-oxidation via SIRT1-BMAL1 pathway in 6-OHDA induced Parkinson’s disease model
- 12:30pm-2:00pm
-
Do different tic phenotypes have different responses to comprehensive behavioral intervention for tics (CBIT)?
- 12:30pm-2:00pm
-
Do environmental factors influence the age at onset of Parkinson’s disease in LRRK2 G2019S carriers?
- 12:30pm-2:00pm
-
Does VIM deep brain stimulation affect swallowing?
- 12:30pm-2:00pm
-
Dopamine D3 receptor Ser9Gly variant is a risk factor for impulse control disorders in Parkinson’s disease
- 12:30pm-2:00pm
-
Drug-induced parkinsonism in Taiwan
- 12:30pm-2:00pm
-
Duodopa for the treatment of severe restless legs syndrome
- 12:30pm-2:00pm
-
Dysregulated macroautophagy and mitochondrial dynamics in PD with glucocerebrosidase mutations
- 12:30pm-2:00pm
-
Effect of genetic variation in SNCA and APOE on cerebrospinal fluid protein levels in patients with Parkinson’s disease and controls
- 12:30pm-2:00pm
-
Effect of L-DOPA on re-emergent tremor in Parkinson’s disease: A neurophysiological assessment
- 12:30pm-2:00pm
-
Effect of marijuana on Essential Tremor: A case report
- 12:30pm-2:00pm
-
Effect of vibration on motor performance: A new intervention to improve bradykinesia in Parkinson’s disease?
- 12:30pm-2:00pm
-
Effect of zonisamide on post-traumatic Holmes’ tremor
- 12:30pm-2:00pm
-
Effects of Arachidonyl-2′-chloroethylamide (ACEA), a selective CB1 receptor agonist, in MPTP mouse model of Parkinson’s disease
- 12:30pm-2:00pm
-
Elevated SNCA expression in CD45+ peripheral blood cells in patients with dementia with Lewy bodies
- 12:30pm-2:00pm
-
Elucidating mechanisms of endogenous disease protection resulting in reduced penetrance in PINK1 deficiency
- 12:30pm-2:00pm
-
Endoscopically-documented pharyngeal dystonia due to neuroleptic use without response to alcohol
- 12:30pm-2:00pm
-
Enteric neurons reveal substantial in vivo mitochondrial changes in Parkinson’s disease
- 12:30pm-2:00pm
-
Epigenome-wide association study of Parkinson’s disease
- 12:30pm-2:00pm
-
Essential tremor: Characterization according to their phenotypes and their association with Parkinsonian signs
- 12:30pm-2:00pm
-
Evaluating Parkinsonian motor features via the routine use of consumer electronics – neuroQWERTY
- 12:30pm-2:00pm
-
Evaluation of kinematic parameters of potential clinical use extracted from Microsoft Kinect V2 motor assessments
- 12:30pm-2:00pm
-
Evaluation of the role of oxidative stress in Parkinson’s disease and Parkinson plus syndrome
- 12:30pm-2:00pm
-
Exome sequencing in dementia with Lewy bodies
- 12:30pm-2:00pm
-
Exosomes-injection to reproduce a mouse model of Parkinson’s disease: A preliminary report
- 12:30pm-2:00pm
-
Expanding the spectrum of PEX10-related peroxisomal biogenesis disorders: Slowly progressive recessive ataxia
- 12:30pm-2:00pm
-
Exploring aging-VMAT2 gene-rotenone interactions in a cell model for Parkinson’s disease
- 12:30pm-2:00pm
-
Fahr’s syndrome in a Filipino female with hearing loss and polycystic ovaries: A case report
- 12:30pm-2:00pm
-
Faithful SGCE imprinting in iPSC-derived cortical neurons: An endogenous model system of myoclonus-dystonia
- 12:30pm-2:00pm
-
Falls in Parkinson’s disease: Beware the short, slow steps
- 12:30pm-2:00pm
-
Familial Parkinson’s disease in Ireland
- 12:30pm-2:00pm
-
Familial Parkinson’s disease in the Province of Quebec
- 12:30pm-2:00pm
-
Familial SPG17/distal hereditary motor neuropathy type V– Complicated hereditary spastic paraplegia with many faces
- 12:30pm-2:00pm
-
Frontal dysfunction in Tourette syndrome: A PET-FDG study
- 12:30pm-2:00pm
-
Functional characterisation and the selective vulnerability of SNCA (A30P) patient-derived midbrain dopaminergic neurons to ER stress
- 12:30pm-2:00pm
-
Gender-age features of autonomic heart rhythm disturbances in Parkinson’s disease patients
- 12:30pm-2:00pm
-
Gene delivery of AAV2-neurturin for patients with Parkinson’s disease: A meta-analysis
- 12:30pm-2:00pm
-
Gene expression analysis using the Parkinson’s disease map reveals early effects of alpha-synuclein on PD pathogenesis
- 12:30pm-2:00pm
-
Gene network driven probable drug target identification: An in-silico study on Parkinson’s disease
- 12:30pm-2:00pm
-
Generation and characterization of midbrain organoids from iPSCs of familial Parkinson’s disease
- 12:30pm-2:00pm
-
Generation of dopaminergic neurons for studying Parkinson’s disease using patient blood cells
- 12:30pm-2:00pm
-
Generation of human induced pluripotent stem cells carrying a safety bet for cell-based therapy in Parkinson’s disease
- 12:30pm-2:00pm
-
Genetic variation near the SNCA gene associates with Parkinson’s disease motor phenotype and progression
- 12:30pm-2:00pm
-
Genome-wide bioinformatic analysis of Parkinson’s disease: A focus on neuronal health maintenance
- 12:30pm-2:00pm
-
Glatiramir acetate (Copaxone) causes restoration of the striatal dopamine in a progressive MPTP mouse model of Parkinson’s disease
- 12:30pm-2:00pm
-
Glucocerebrosidase activity in a cohort of PD patients
- 12:30pm-2:00pm
-
Glutathione status in Parkinson’s disease
- 12:30pm-2:00pm
-
Gustatory function of patients with essential tremor and its correlation with olfactory and cognitive functions
- 12:30pm-2:00pm
-
Hemi-stereotypies symptomatic to aneurysm: Differential diagnosis of tardive dyskinesia
- 12:30pm-2:00pm
-
Hemifacial spasm – Therapeutic assessment of botulinum toxin
- 12:30pm-2:00pm
-
High throughput pooled-DNA sequencing of mendelian/susceptibility Parkinson’s disease genes in Spanish population
- 12:30pm-2:00pm
-
Histochemical evaluation of the effect of vitamin E on cyanide–induced damage on the prefrontal cortex of Sprague Dawley rats
- 12:30pm-2:00pm
-
Histone deacetylase 4 is regulated by microRNA 128 in SH-SY5Y cells of Parkinson’s disease
- 12:30pm-2:00pm
-
Hyperin inhibits lipopolysaccharide-induced microglia activation through p38 and NFκB signaling
- 12:30pm-2:00pm
-
ICF-based effects of VIM-DBS on communication in everyday life in patients with essential tremor
- 12:30pm-2:00pm
-
Identifying freezing of gait and falls in Parkinson’s disease patients using a body-worn sensor
- 12:30pm-2:00pm
-
IL-6 and motor symptoms in Parkinson’s disease
- 12:30pm-2:00pm
-
Impact of prolonged temporal discrimination threshold on finger movements of Parkinson’s disease
- 12:30pm-2:00pm
-
Impairments in trunk muscle function influence head and trunk stability during walking in Parkinson’s disease fallers
- 12:30pm-2:00pm
-
In utero delivery of scAAV9 mediates widespread brain transduction in rats and monkeys: Towards new models of Parkinson’s disease
- 12:30pm-2:00pm
-
Incidence of waning tremor control in essential tremor patients with deep brain stimulation
- 12:30pm-2:00pm
-
Incidental finding of drug-induced movement disorder
- 12:30pm-2:00pm
-
Increased cellular co-localization of tau fragment 1-368 and alpha-synuclein in two mouse model of Parkinson’s disease
- 12:30pm-2:00pm
-
Increased cerebrospinal fluid lactate levels in Parkison’s disease: Is it a proof of mitochondrial inefficiency?
- 12:30pm-2:00pm
-
Individualized botulinum toxin type A therapy of bilateral upper limb essential tremor by multi-sensor kinematic technology
- 12:30pm-2:00pm
-
Induced pluripotent stem cell-derived cortical neurons as a disease model for X-linked dystonia-parkinsonism
- 12:30pm-2:00pm
-
Inhibition of the mitochondrial calcium uniporter (MCU) rescues dopaminergic neurons in pink1-/- zebrafish
- 12:30pm-2:00pm
-
Insulin dependent diabetes and hand tremor
- 12:30pm-2:00pm
-
Interest in genetic testing in Parkinson’s disease patients with deep brain stimulation
- 12:30pm-2:00pm
-
Intracerebroventricular D-galactose injection provokes motor coordination impairment and cerebellar damage in Wistar rats
- 12:30pm-2:00pm
-
Intracranial calcifications in children and adults: Molecular and phenotypic characterization from a tertiary referral centre
- 12:30pm-2:00pm
-
Intrastriatal injection of ionomycin profoundly changes motor response to L-DOPA and its underlying molecular mechanisms
- 12:30pm-2:00pm
-
Investigation into the genetic etiology in South African Parkinson’s disease patients
- 12:30pm-2:00pm
-
Involvement of cerebellothalamocortical pathway in essential tremor and dystonic tremor
- 12:30pm-2:00pm
-
Is the assessment of 5 meters of gait with body-worn-sensors enough to recognize Parkinsonian gait?
- 12:30pm-2:00pm
-
Is tremor related to celiac disease?
- 12:30pm-2:00pm
-
Kinematic analysis of repetitive finger movements and the effects of selegiline and pramipexole in early Parkinson’s disease
- 12:30pm-2:00pm
-
L-dopa-responsive, diurnally fluctuating auricular tremor with tetrahydrobiopterin (BH4) deficiency
- 12:30pm-2:00pm
-
Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with idiopathic Parkinson’s disease
- 12:30pm-2:00pm
-
LC3 deacetylation by SIRT1 is involved in neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson’s disease
- 12:30pm-2:00pm
-
Levodopa-responsive hereditary spastic paraplegia, SPG35, due to FA2H mutations in siblings
- 12:30pm-2:00pm
-
Localization and functional study of synaptic vesicle protein synaptogyrin-3 (SYNGR3) on dopaminergic neuronal system
- 12:30pm-2:00pm
-
Long term recordings of subthalamic ocillatory activity in patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Longitudinal cerebrospinal fluid biomarkers in early Parkinson’s disease and healthy controls
- 12:30pm-2:00pm
-
Longitudinal follow-up of the association of tic disorders with poor academic performance
- 12:30pm-2:00pm
-
Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson’s disease subtype
- 12:30pm-2:00pm
-
Lrrk2 alleles modify host response to microbial infections
- 12:30pm-2:00pm
-
LRRK2 G2019S mutation carrier with an unusual phenotype: Progressive logopenic aphasia
- 12:30pm-2:00pm
-
Lymphocytes have a detrimental effect on motor behavior in the AAV1/2 A53T α-synuclein mouse model of Parkinson’s disease
- 12:30pm-2:00pm
-
Lysosomal alterations in peripheral blood mononuclear cells of Parkinson’s disease patients
- 12:30pm-2:00pm
-
Medical cannabis for the treatment of Tourette syndrome: A descriptive analysis of 24 patients
- 12:30pm-2:00pm
-
Microglia P2Y6 receptor is related to Parkinson’s disease and involved in the neuroinflammatory process
- 12:30pm-2:00pm
-
Mild mitochondrial impairment promotes corticostriatal synaptic plasticity alterations in PINK1 heterozygous knockout mice
- 12:30pm-2:00pm
-
Mitochondrial cardiolipin couples electron transport between ubiquinone and complex I to rescue PINK1 deficiency
- 12:30pm-2:00pm
-
Mitochondrial dysfunction in skin fibroblasts from single heterozygous ATP13A2 (PARK9) mutation carriers
- 12:30pm-2:00pm
-
Mitochondrial Hsp90 inhibitor G-TTP triggers PINK1/parkin-dependent mitochondrial quality control
- 12:30pm-2:00pm
-
Mitochondrial response precedes intracellular accumulation of α-synuclein in Parkinson’s disease
- 12:30pm-2:00pm
-
Mitochondrial-nuclear interplay in single respiratory chain-deficient Parkinson’s disease neurons
- 12:30pm-2:00pm
-
Mixed tremor with cryptogenic atrophy of dominant hemisphere, diagnostic and treatment challenges
- 12:30pm-2:00pm
-
Modulation of microglia function in the prion-like spreading of α-synuclein in the murine brain
- 12:30pm-2:00pm
-
Modulation of thalamocortical network dynamics via deep brain stimulation in humans with Tourette syndrome
- 12:30pm-2:00pm
-
Molecular landscape of Parkinson’s disease reveals a key role for lipids and lipoproteins
- 12:30pm-2:00pm
-
Monitoring dyskinesia severity using wearable sensor data
- 12:30pm-2:00pm
-
Monitoring oxidative stress and progression to cell death: From secretome to blood diagnosis
- 12:30pm-2:00pm
-
mPower: A smartphone-based study of Parkinson’s disease provides personalized measures of disease impact
- 12:30pm-2:00pm
-
Multidisciplinary group program integrating voice and dance movement therapy for Parkinson’s disease patients: Preliminary experience
- 12:30pm-2:00pm
-
Mutant WDR45 links NBIA to impaired autophagy, mitochondrial dysfunction and oxidative stress
- 12:30pm-2:00pm
-
Myoclonus complicating chickenpox: A case report
- 12:30pm-2:00pm
-
Myoclonus Dystonia: A report of two rare mutations
- 12:30pm-2:00pm
-
Neurodegeneration and microgliosis are independent of α-synuclein aggregation in a mouse model of "prion-like" α-synuclein speading
- 12:30pm-2:00pm
-
Neurodegeneration with brain iron accumulation (NBIA): Two cases with different subtypes and a rare mutation
- 12:30pm-2:00pm
-
Neuromelanin imaging is useful for monitoring disease progression in Parkinson’s disease and PARK2
- 12:30pm-2:00pm
-
Next-generation profiling to identify the molecular etiology of Parkinson’s disease dementia
- 12:30pm-2:00pm
-
Ninjurin 1 gene D110a single nucleotide polymorphism as a genetic marker for nerve damage leprosy patients from South India
- 12:30pm-2:00pm
-
Non-motor symptoms profiles in UK white Caucasian and Asian as well as overseas Thai and East Indian patients with Parkinson’s disease
- 12:30pm-2:00pm
-
Nystagmus in essential tremor
- 12:30pm-2:00pm
-
Objective data in Parkinson’s disease therapy management – A retrospective analysis of the Parkinson’s kinetigraph (PKG) database
- 12:30pm-2:00pm
-
Oculopalatal myoclonus after stroke
- 12:30pm-2:00pm
-
Olfaction and gray matter volume in Parkinson’s disease. A voxel-based morphometry study
- 12:30pm-2:00pm
-
Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson’s disease
- 12:30pm-2:00pm
-
Opsoclonus myoclonus ataxia syndrome in a seronegative patient with disseminated cryptococcosis: The first case report
- 12:30pm-2:00pm
-
Optimization of 6-hydroxydopamine animal model of early stage Parkinson´s disease for the assessment of neurorestorative therapies
- 12:30pm-2:00pm
-
Oral apomorphine film (APL-130277) produces no buccal mucosal irritation: Results of a toxicological study
- 12:30pm-2:00pm
-
Orthostatic tremor: A literature review of clinical data
- 12:30pm-2:00pm
-
Orthostatic tremor: Disease progression and disability
- 12:30pm-2:00pm
-
Ortostatic myoclonus: A report of four cases
- 12:30pm-2:00pm
-
Paroxysmal exercise-induced dystonia within the phenotypic spectrum of ECHS1 deficiency
- 12:30pm-2:00pm
-
Pathophysiological mechanisms of bone mass loss for osteoporosis prevalence in Parkinson’s disease
- 12:30pm-2:00pm
-
Persistent myoclonic dystonia due to SCL2A1 mutation
- 12:30pm-2:00pm
-
Phenotypic characteristics in GBA-associated Parkinson’s disease (PD): A study in a Greek population
- 12:30pm-2:00pm
-
Phosphorylation by GSK-3β enhances binding of metal ion induced tau oligomers to neutral lipid surfaces
- 12:30pm-2:00pm
-
Physical training prevents depressive-like behavior and bdnf decrease in an animal model of Parkinson’s disease
- 12:30pm-2:00pm
-
PINK1-dependent clearance of depolarized mitochondria is driven by the UPS and can occur independently of (macro)autophagy
- 12:30pm-2:00pm
-
Piper longum L. alkaloids inhibit lipopolysaccharide-stimulated microglial activation and protect nigral dopaminergic neurons
- 12:30pm-2:00pm
-
Post-anoxic myoclonus: Timing matters
- 12:30pm-2:00pm
-
Post-traumatic rubral tremor – A rare entity
- 12:30pm-2:00pm
-
Postural and nonmotor disturbances in Parkinson’s disease
- 12:30pm-2:00pm
-
Pre-formed fibrils injection worsen pathology caused by AAV-mediated over expression of α-synuclein
- 12:30pm-2:00pm
-
Premotor phase of PD in two GBA mutation carriers
- 12:30pm-2:00pm
-
Prescribed gait tests versus continuous monitoring of gait in people with Parkinson’s disease
- 12:30pm-2:00pm
-
Primary progressive aphasia and frontotemporal dementia in an Irish-American family due to a novel progranulin mutation
- 12:30pm-2:00pm
-
Protective effects of ATP13A2 in Parkinson’s disease models
- 12:30pm-2:00pm
-
Quantification of postural stability in Parkinson’s disease patients utilizing mobile technology
- 12:30pm-2:00pm
-
Quantifying daily living transitions in patients with Parkinson’s disease using a body-fixed sensor
- 12:30pm-2:00pm
-
Quantitative assessment of advanced therapies in Parkinson’s disease using the Parkinson kinetigraph (PKG)
- 12:30pm-2:00pm
-
Quantitative assessment of DBS-induced gait disorder in patients with essential tremor
- 12:30pm-2:00pm
-
Reduced thalamo-cortical functional connectivity in asymptomatic LRRK2 mutation carriers
- 12:30pm-2:00pm
-
Regulation in speech motor control in ET patients treated with DBS: Kinematics of the lingual and the labial systems
- 12:30pm-2:00pm
-
Relationship of serum ferritin level and tic severity in children with Tourette syndrome
- 12:30pm-2:00pm
-
Reliability and responsiveness of in-clinic and at-home app-based bradykinesia assessment
- 12:30pm-2:00pm
-
Response to thermal and pain stimulation and genetic variance for pain in patients with Parkinson’s disease – Are they all related?
- 12:30pm-2:00pm
-
Risk of movement disorders with antipsychotic drugs in patients with schizophrenia or depressive disorders
- 12:30pm-2:00pm
-
Risk prediction modeling in Parkinson’s disease using genetic and environmental/lifestyle factors
- 12:30pm-2:00pm
-
Role of macroautophagy in regulating microglia-mediated neuroinflammation and dopaminergic neuron injury
- 12:30pm-2:00pm
-
Roles of combined functional catechol-o-methyltransferase genotypes in Chinese Parkinson’s disease: A cross-sectional survey
- 12:30pm-2:00pm
-
Same cerebellar atrophy pattern in hyper- and hypokinetic movement disorders due to mitochondrial cytopathy
- 12:30pm-2:00pm
-
Selenotranscriptomic analyses identify signature selenoproteins in brain regions in a mouse model of Parkinson’s disease
- 12:30pm-2:00pm
-
Serum levels of polychlorinated biphenyls, CYP2B6 and neurodegenerative disease in the Faroe Islands
- 12:30pm-2:00pm
-
Sleep in essential tremor patients: A polysomnographic study
- 12:30pm-2:00pm
-
Sleep motor activity in amyotrophic lateral sclerosis
- 12:30pm-2:00pm
-
Sleep related disorders in subtypes of patients with Parkinson’s disease in the Tomsk region, Russia
- 12:30pm-2:00pm
-
SMPD1 mutations, acid-sphingomyelinase activity and α-synuclein accumulation in Parkinson’s disease
- 12:30pm-2:00pm
-
SOD1 aggregation: A pathological link between Parkinson’s disease and amyotrophic lateral sclerosis?
- 12:30pm-2:00pm
-
Sodium butyrate attenuates rotenone-induced neurodegeneration via enhancing autophagy and preventing α-synuclein aggregation
- 12:30pm-2:00pm
-
Spastic gait and mechanical energy recovery in children with hereditary spastic paraplegia
- 12:30pm-2:00pm
-
SPAsticity in PractiCE (SPACE) – An international, observational study of botulinum toxin type A in spasticity
- 12:30pm-2:00pm
-
Speed and severity of toxicity induced by pre-formed α-synuclein fibrils in rat brain is enhanced by α-synuclein overexpression
- 12:30pm-2:00pm
-
Striatal PDE10 expression in Parkinson’s disease (PD) and healthy controls using [18F]MNI-659 PET imaging
- 12:30pm-2:00pm
-
Study on association between physical and genetics role in essential tremor – A case control study
- 12:30pm-2:00pm
-
Substantia nigra α4β2 nicotinic cholinergic receptor expression correlates with tremor in Parkinson’s disease
- 12:30pm-2:00pm
-
Substantial motor and non-motor symptoms in children and adults with classical galactosemia and organic acidurias
- 12:30pm-2:00pm
-
Survey of telemedicine use among MDS members
- 12:30pm-2:00pm
-
Symptomatic palatal and respiratory tremor with ataxia following fourth ventricle epidermoid cyst removal
- 12:30pm-2:00pm
-
Synaptic homeostasis in Parkinson’s disease: An high-density EEG study in different stage of the disease
- 12:30pm-2:00pm
-
Systematic review and meta-analysis of randomized controlled trials to evaluate placebo response in restless legs syndrome
- 12:30pm-2:00pm
-
Systematic review of autosomal recessive parkinsonism using the MDGene database protocol
- 12:30pm-2:00pm
-
TAF1 and its isoforms is underexpressed in different endogenous models of X-linked dystonia-parkinsonism
- 12:30pm-2:00pm
-
Technology use habits and preferences of a population with Parkinson’s disease and their care partners
- 12:30pm-2:00pm
-
Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease
- 12:30pm-2:00pm
-
The contribution of the subthalamic nucleus in gait initiation of subjects with Parkinson’s disease
- 12:30pm-2:00pm
-
The distinguishing clinical features of rapid-onset-parkinson-dystonia (RDP) syndrome due to ATP1A3 mutations
- 12:30pm-2:00pm
-
The Faroese Parkinson’s diseases research program-Multifactorial analyses of a complex syndrome
- 12:30pm-2:00pm
-
The French experience of liver transplantation for severe neurological forms of Wilson disease
- 12:30pm-2:00pm
-
The impact of levodopa and apomorphine on beta- and gamma-oscillations in cortico-basal ganglia circuits in experimental parkinsonism
- 12:30pm-2:00pm
-
The phenotypic and genetic features of myoclonus-dystonia in six Saudi Arabian kindreds
- 12:30pm-2:00pm
-
The relevance of movement disorders gene panels in clinical practice: How many patients are we sorting out?
- 12:30pm-2:00pm
-
The role of non-steroidal anti-inflammatory use in symptomatic and asymptomatic LRRK2 G2019S mutation carriers
- 12:30pm-2:00pm
-
The small GTP-binding protein Rhes influences midbrain dopaminergic neurons: Behavioral and biochemical studies
- 12:30pm-2:00pm
-
The temporal relationship between premonitory sensations and tics compared to obsessions
- 12:30pm-2:00pm
-
Tick disorders in children and differential diagnosis with progressive diseases of the nervous system
- 12:30pm-2:00pm
-
Tics exacerbations in middle-aged and older adults with Tourette syndrome: A case series
- 12:30pm-2:00pm
-
To new method of tremor assessment
- 12:30pm-2:00pm
-
Toward a new biomarker on Parkinson’s disease: Study of alpha synuclein on upper enteric system by endoscopy
- 12:30pm-2:00pm
-
Transcriptional profile of blood leukocyte in Parkinson’s disease patients after multi-modal exercise and tai chi training
- 12:30pm-2:00pm
-
Transient myoclonic state in the elderly: A new entity in the classification of myoclonus
- 12:30pm-2:00pm
-
Transient parkinsonism during pregnancy in patient heterozygous for Gaucher’s disease: Case report
- 12:30pm-2:00pm
-
Treatment of OFF episodes in Parkinson’s disease: An evaluation of patient and caregiver insights
- 12:30pm-2:00pm
-
Treatment of OFF episodes in Parkinson’s disease: An evaluation of physician practices
- 12:30pm-2:00pm
-
Tremor amplitude detected by three-dimensional optical device provides good correlation to clinical rating scale
- 12:30pm-2:00pm
-
Tremor-recording methods and related quantitative tremor parameters in Parkinson’s disease
- 12:30pm-2:00pm
-
Triple X syndrome: Are tremors part of its phenotype?
- 12:30pm-2:00pm
-
Turkish version of the Johns Hopkins restless legs syndrome quality of life questionnaire (RLS-QoL): Validity and reliability study
- 12:30pm-2:00pm
-
Two cases of parkinsonism with atypical genetics
- 12:30pm-2:00pm
-
Two siblings with action myoclonus renal failure syndrome
- 12:30pm-2:00pm
-
Two-step induction of dopaminergic neurons – Differentiation of leukapharesis-derived mesenchymal stem cells
- 12:30pm-2:00pm
-
Unconventional chaperone inhibits alpha-synuclein amyloid formation by promoting off-pathway aggregation
- 12:30pm-2:00pm
-
Urate and homocysteine: Changes in motor and cognitive symptoms in newly diagnosed Parkinson’s disease
- 12:30pm-2:00pm
-
Vascular degeneration in Parkinson’s disease
- 12:30pm-2:00pm
-
Video-based tremor analysis via Kinect® System in comparison to accelerometric and electromyographical tremor detection
- 12:30pm-2:00pm
-
Vitamin D in early Parkinson’s disease
- 12:30pm-2:00pm
-
Vitamin D receptor polymorphisms and Parkinson’s disease in a Korean population: Revisited
- 12:30pm-2:00pm
-
Wrist reveals the fall risk in activities of daily living
- 12:30pm-2:00pm
-
Young-onset Parkinson’s disease in two siblings with compound heterozygosity for two rare parkin mutations
- 12:00pm-1:30pm
-
[18F]AV-1451 PET imaging of tau in progressive supranuclear palsy and Alzheimer’s disease
- 12:00pm-1:30pm
-
In vivo evaluation of tau pathologies in patient with progressive supranuclear palsy and healthy subjects with [11C]PBB3-PET
- 12:00pm-1:30pm
-
A case of misdiagnosed Parkinson’s disease (PD)
- 12:00pm-1:30pm
-
A cross-sectional study in spinocerebellar ataxia type 12 (SCA-12) patients from a tertiary care center in Eastern India
- 12:00pm-1:30pm
-
A health cost analysis for Huntington disease in Peru
- 12:00pm-1:30pm
-
A largest case series study of spinocerebellar ataxia type 2(SCA2) from India: Do SCA2 clinical subtypes exists?
- 12:00pm-1:30pm
-
A longitudinal study of functional deterioration of primary olfactory cortex in early-stage Parkinson’s disease
- 12:00pm-1:30pm
-
A technological solution for monitoring Parkinson’s disease: A patient-based perspective on necessity, usability and acceptability
- 12:00pm-1:30pm
-
A unique phenotype associated with anti-GAD antibodies
- 12:00pm-1:30pm
-
Abnormal findings in polisomnographic records of patients with spinocerebellar ataxia type 2 (SCA2)
- 12:00pm-1:30pm
-
Accuracy of clinical diagnosis of dementia with Lewy bodies: A systematic review and meta-analysis
- 12:00pm-1:30pm
-
Acute cerebellar degeneration as the first manifestation of Sjögren syndrome: A case report
- 12:00pm-1:30pm
-
Affective theory of mind in Parkinson’s disease
- 12:00pm-1:30pm
-
Altered brain activation in complex walking conditions in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Altered resting-state functional interhemispheric connectivity in Parkinson’s disease
- 12:00pm-1:30pm
-
Alternatives for reducing chorea in Huntington disease, a long-term trial (ARC-HD): Updated week 8 results for the switch cohort
- 12:00pm-1:30pm
-
Ambulatory assessment of tremor
- 12:00pm-1:30pm
-
Analysis of cognitive disorders of Parkinson’s disease (PD) in the comparative aspect
- 12:00pm-1:30pm
-
Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination
- 12:00pm-1:30pm
-
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease
- 12:00pm-1:30pm
-
Apraxia in Parkinson’s disease
- 12:00pm-1:30pm
-
Arterial spin labeling perfusion MRI compensate for other diagnostic tools in evaluation of Parkinson’s disease with dementia
- 12:00pm-1:30pm
-
Assessment of cognitive-motor interference during an upper extremity motor task in Parkinson’s disease
- 12:00pm-1:30pm
-
Assessment of subclinical cerebellar involvement in progressive supranuclear palsy using SUIT based volumetric analysis
- 12:00pm-1:30pm
-
Association between cognitive status and mobility performance in dual task condition in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Association between urine protein/creatinine ratio and cognitive dysfunction in Parkinson’s disease
- 12:00pm-1:30pm
-
Association or causation? Orthostatic hypotension and cognitive impairment in α-synucleinopathies: A systematic review
- 12:00pm-1:30pm
-
Attention to action: Common to both conversion (psychogenic) and Parkinsonian (neurogenic) motor speech disorders
- 12:00pm-1:30pm
-
Automatic event-detection for the neurophysiological evaluation of voluntary and involuntary movements
- 12:00pm-1:30pm
-
Autosomal recessive ataxia due to ANO10 mutations; full and novel phenotypic data in an Irish pedigree
- 12:00pm-1:30pm
-
Balance in patients with newly diagnosed Parkinson´s disease – A three year follow-up of a cohort in Northern Sweden
- 12:00pm-1:30pm
-
Baseline physical activity may influence exercise-induced changes in cognitive function in Parkinson’s disease
- 12:00pm-1:30pm
-
Behavioral and neuroimaging effects of LSVT-BIG and conventional physiotherapy in Parkinson’s disease
- 12:00pm-1:30pm
-
Brain iron levels in Parkinson’s disease by postmortem and MRI measurements: A systematic review and meta-analysis
- 12:00pm-1:30pm
-
Can quantitative analysis of the “finger-to-nose test” discern between EOA and other conditions of coordination impairment?
- 12:00pm-1:30pm
-
Catechol-o-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson’s disease
- 12:00pm-1:30pm
-
Cerebellar ataxia and pregnancy
- 12:00pm-1:30pm
-
Cerebellar GABA-A receptor activity is inversely correlated with gait speed in Parkinson’s disease
- 12:00pm-1:30pm
-
Cerebellar gray matter alterations in Huntington disease: A voxel-based morphometry study
- 12:00pm-1:30pm
-
Cerebrospinal fluid biomarkers in Parkinson’s disease and associated cognitive impairment
- 12:00pm-1:30pm
-
Changes of brain structure and cognition in individuals with possible prodromal Parkinson’s disease
- 12:00pm-1:30pm
-
Characteristics of drop outs in a longitudinal study on individuals at risk for a neurodegenerative disorder
- 12:00pm-1:30pm
-
Characterization and quantitative analysis of prelemniscal radiations in Parkinson´s disease
- 12:00pm-1:30pm
-
Choreoathetosis associated with cervical dystonia as clinical presentation of thyrotoxicosis: A rare condition
- 12:00pm-1:30pm
-
Circulatory levels of BDNF correlate with cognitive deficits in people with Parkinson’s disease
- 12:00pm-1:30pm
-
Clinical and analytical validation of novel autosomal recessive ataxia mutations identified from whole exome sequencing
- 12:00pm-1:30pm
-
Clinical and behavioral features in carriers of intermediate length alleles of HTT gene. A case series of Mexican population
- 12:00pm-1:30pm
-
Clinical and imaging characteristics of spinocerebellar ataxia type 14 defined in a German multi-center sample
- 12:00pm-1:30pm
-
Clinical and instrumental gait analysis study of fear of falling in Parkinson’s disease patients
- 12:00pm-1:30pm
-
Clinical presentation and genetic characteristics of Huntingtons disease in Croatia: Thirty years of experience
- 12:00pm-1:30pm
-
Cognitive and behavioral problems in children and adolescents with myoclonus dystonia
- 12:00pm-1:30pm
-
Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension
- 12:00pm-1:30pm
-
Cognitive deficits in Parkinson’s disease: A preliminary study of neuropsychological profiles
- 12:00pm-1:30pm
-
Cognitive impairment in Huntington’s disease
- 12:00pm-1:30pm
-
Combined effects of visual and auditory cues on gait initiation in Parkinson’s disease
- 12:00pm-1:30pm
-
Combined imaging markers increase accuracy when predicting real life disease onset in Huntington’s disease
- 12:00pm-1:30pm
-
Communication and language skills in Huntington’s disease
- 12:00pm-1:30pm
-
Comparative analysis of clinical and neuroimaging features of parkinsonism and dementia of Alzheimer’s type
- 12:00pm-1:30pm
-
Comparative analysis of upper limb motor function and articulation disorder in Parkinson’s disease
- 12:00pm-1:30pm
-
Comparative study of the substantia nigra echogenicity and 123-I ioflupane SPECT in patients with REM behavior disorder
- 12:00pm-1:30pm
-
Comparison of DAT and DOPA PET tracer for assessing severity and progression in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Comparison of DAT scan, cardiac MIBG scintigraphy, and cerebrospinal fluid 5HIAA levels in Parkinsonian syndrome
- 12:00pm-1:30pm
-
Comparison of mental practice and proprioceptive neuromuscular facilitation in sisters with cerebellar atrophy
- 12:00pm-1:30pm
-
Comparison of Test Your Memory (TYM) and Montreal Cognitive Assessment (MoCA) measures in Parkinson’s disease
- 12:00pm-1:30pm
-
Compensation strategies for gait in Parkinson’s disease
- 12:00pm-1:30pm
-
Computer uses and difficulties in Parkinson’s disease
- 12:00pm-1:30pm
-
Consolidation of learning and memory in Parkinson’s disease
- 12:00pm-1:30pm
-
Construct validity of Moca test in a sample of patients with Parkinson´s disease in Bogotá and Cali – Colombia
- 12:00pm-1:30pm
-
Core set of measures of balance for people with multiple sclerosis and cerebellar ataxia
- 12:00pm-1:30pm
-
Corpus callosum thickness and area in Parkinson’s disease
- 12:00pm-1:30pm
-
Correlation analysis for postural instability and autonomic dysfunction in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Correlation between neuro-behavioral symptoms, cognition and gait in patients with dementia with Lewy bodies (DLB)
- 12:00pm-1:30pm
-
Cortical excitability in patients with Parkinson’s disease on levodopa carbidopa intestinal gel thereapy
- 12:00pm-1:30pm
-
Cortical grey matter atrophy in the motor system in Friedreich ataxia: The IMAGE-FRDA study
- 12:00pm-1:30pm
-
CSF inflammatory and cell death biomarkers in Huntington’s disease – An exploratory cross-sectional study
- 12:00pm-1:30pm
-
DAT SPECT data of Parkinson’s disease patients with and without REM Sleep Pathology: A report from the DeNoPa cohort
- 12:00pm-1:30pm
-
Decline in drawing ability associated with frontal dysfunction after subthalamic nucleus deep brain stimulation in Parkinson’s disease
- 12:00pm-1:30pm
-
Deep brain stimulation of the dentate nucleus improves ataxia and modulates cortical excitability
- 12:00pm-1:30pm
-
Deficits in sensorimotor networks in functional movement disorders: A graph-theory based network analysis
- 12:00pm-1:30pm
-
Density of metabotropic glutamate receptors subtype 1 in de novo patients with Parkinson’s disease using 11C-ITMM PET
- 12:00pm-1:30pm
-
Developmental movement patterns resemble movement disorder features in healthy babies and toddlers
- 12:00pm-1:30pm
-
Diagnosis and management of dementia with Lewy bodies: Influence of concomitant cerebrovascular disease
- 12:00pm-1:30pm
-
Diagnostic performance of the Spanish version of the 19-items wearing-off questionnaire in Mexican patients with PD
- 12:00pm-1:30pm
-
Diffusion tensor imaging in Parkinson’s disease: Review and meta-analysis with clinical considerations and neuroimaring parameters
- 12:00pm-1:30pm
-
Diffusion tensor imaging of corticospinal tract, cingulum and corpus callosum in Parkinson’s disease (PD) patients
- 12:00pm-1:30pm
-
Diffusion tensor imaging of the corticospinal tract differentiates Parkinson’s disease (PD) patients from controls
- 12:00pm-1:30pm
-
Diffusion tensor metrics of thalamic degeneration and postural instability in Parkinson’s disease
- 12:00pm-1:30pm
-
Disease-related variables effect on depression and anxiety level in Parkinson’s patients
- 12:00pm-1:30pm
-
Disrupted motor memory in Parkinson’s disease
- 12:00pm-1:30pm
-
Disruption of functional connectivity in Parkinson’s disease patients presenting phonemic fluency impairment
- 12:00pm-1:30pm
-
Does cognitive decline contribute to poorer quality of life in incident Parkinson’s disease? A three year follow up
- 12:00pm-1:30pm
-
Dopamine modulates learning conflicting action-valence associations in Parkinson’s disease
- 12:00pm-1:30pm
-
Dopaminergic and non-dopaminergic effects on instrumented timed up and go test in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Dopaminergic drug management in Parkinson’s disease: Gait and language function show correlation during treatment
- 12:00pm-1:30pm
-
DTI in Parkinson’s disease: Asymmetric progression
- 12:00pm-1:30pm
-
Dyskinesias-reduced-self-awareness and theory of mind in Parkinson’s disease: A novel frame of interpretation
- 12:00pm-1:30pm
-
Dysphagia in early stage Huntington’s disease (HD) – Pilot observations from a multimodal imaging study
- 12:00pm-1:30pm
-
Early clinical features of paraneoplastic cerebellar degeneration: Diagnostic outcomes of adult onset cerebellar ataxia
- 12:00pm-1:30pm
-
EARLYSTIM: STN-DBS alleviates behavioural side effects of dopamine replacement therapy when compared to best medical treatment
- 12:00pm-1:30pm
-
Effect of rivastigmine in Parkinson’s disease dementia – A logitudinal observational study
- 12:00pm-1:30pm
-
Effectiveness of Levodopa responsiveness of Blink reflex recovery: An objective method to differentiate Parkinsonian syndromes
- 12:00pm-1:30pm
-
Effects of age and gender on brainstem MR-planimetry
- 12:00pm-1:30pm
-
Effects of dual task on upper extremity function and postural control in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Effects of zonisamide on dementia with Lewy bodies (DLB): A post-hoc analysis of phase 2 study for parkinsonism in DLB patients
- 12:00pm-1:30pm
-
Emotional modulation of the startle reflex in essential tremor: Evidence of altered cerebellar input into limbic circuitry?
- 12:00pm-1:30pm
-
Epidemiology and economic burden of falls and fractures in patients with Huntington’s disease
- 12:00pm-1:30pm
-
Esophageal involvement in multiple system atrophy
- 12:00pm-1:30pm
-
European pediatric normative values for the scale for assessment and rating of ataxia (SARA)
- 12:00pm-1:30pm
-
Evaluating bradykinesia: How many finger taps are needed?
- 12:00pm-1:30pm
-
Evaluating quantitative EEG (QEEG) measures to differentiate between Parkinson’s disease (PD) patients and healthy individuals
- 12:00pm-1:30pm
-
Evaluating swallowing function in patients with Huntington disease enrolled in the first-HD study
- 12:00pm-1:30pm
-
Evaluating the effects of deep brain stimulation (DBS) in mice with spinocerebellar ataxia (SCA1)
- 12:00pm-1:30pm
-
Evaluation of parkinsonism and striatal dopamine transporter loss in patients with spinocerebellar ataxia type 6
- 12:00pm-1:30pm
-
Evaluation of the surface based measures to discriminate progressive supranuclear palsy from corticobasal syndrome
- 12:00pm-1:30pm
-
Evidence of striatal dopaminergic dysfunction Sydenham’s chorea in remission with (99m)Tc-TRODAT-1 SPECT
- 12:00pm-1:30pm
-
Excessive daytime sleepiness is mediated by loss of caudate dopaminergic function in Parkinson’s disease
- 12:00pm-1:30pm
-
Exploring the brainstem functions in cervical dystonia
- 12:00pm-1:30pm
-
Extensive bilateral basal ganglia and cerebellar calcification in Fahr’s syndrome after thyroidectomy
- 12:00pm-1:30pm
-
Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases
- 12:00pm-1:30pm
-
Facial expressivity in Parkinson’s disease (PD) via an examination of smiling behavior: Preliminary findings
- 12:00pm-1:30pm
-
Fall prediction in Parkinson’s disease based on motor dual-tasking: Evidence from the prospective MODEP study
- 12:00pm-1:30pm
-
Fast and simple non-invasive screening tool for mitochondrial changes in Huntington’s disease
- 12:00pm-1:30pm
-
Feasibility and effectiveness of a low-threshold psychoeducative group-intervention for depression in Parkinson’s disease
- 12:00pm-1:30pm
-
Fiberoptic endoscopic evaluation of swallowing findings in patients with Machado-Joseph disease
- 12:00pm-1:30pm
-
Fifteen years of clinical trials in Huntington’s disease: Too many clinical trial failures
- 12:00pm-1:30pm
-
Fractionating apathy – Effort, reward and impulsivity mechanisms in Parkinson’s and Huntington’s disease
- 12:00pm-1:30pm
-
Freezing of gait (FOG) in PD: Is electroencephalography (EEG) a gateway to elucidating the pathophysiology?
- 12:00pm-1:30pm
-
Freezing of gait in extrapontine myelinolysis
- 12:00pm-1:30pm
-
Freezing of gait in Parkinson’s disease: A stopping deficit?
- 12:00pm-1:30pm
-
Freezing of gait is associated with more fear of falling avoidance behavior and less participation in daily physical activity
- 12:00pm-1:30pm
-
Frequency of echogenic abnormality of the substantia nigra is increased in methamphetamine users
- 12:00pm-1:30pm
-
Frontal cortex grey matter integrity determines motor improvement after STN-DBS in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Frontal lobe white matter atrophy correlates with disability in spastic paraplegia type 11 (SPG11)
- 12:00pm-1:30pm
-
Functional connectivity alterations in Parkinson’s disease patients with impulsive control disorders
- 12:00pm-1:30pm
-
Functional connectivity during resting state in Parkinson’s disease patients with and without mild cognitive impairment
- 12:00pm-1:30pm
-
Functional connectivity underpinnings of fatigue in “drug-naïve” patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Functional connectome organization is altered in PD patients with mild cognitive impairment
- 12:00pm-1:30pm
-
Functional deficits during response inhibition improve after dopaminergic medication for Parkinson
- 12:00pm-1:30pm
-
Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease
- 12:00pm-1:30pm
-
GAITRite comparison between Parkinson’s disease stages
- 12:00pm-1:30pm
-
Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson’s disease
- 12:00pm-1:30pm
-
Globus pallidus interna oscillatory activity differentiates tics from voluntary movements and the Parkinsonian resting state
- 12:00pm-1:30pm
-
Gray/white matter contrast loss correlates with clinical severity and visuospatial impairment in Parkinson’s disease patients
- 12:00pm-1:30pm
-
Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD)
- 12:00pm-1:30pm
-
Head drop in patient with Parkinson’s disease as an alert of upcoming myasthenic chrisis
- 12:00pm-1:30pm
-
Heart rate variability to differentiate dementia with Lewy bodies from Alzheimer’s disease in patients with mild cognitive impairment
- 12:00pm-1:30pm
-
How do we make mistakes diagnosing movement disorders?
- 12:00pm-1:30pm
-
How does cognition affect reaching in Parkinson’s disease?
- 12:00pm-1:30pm
-
How does preprocessing affect estimation of causal information transfer in the human brain?
- 12:00pm-1:30pm
-
Illusional perception in Parkinson’s disease
- 12:00pm-1:30pm
-
Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists
- 12:00pm-1:30pm
-
Impact of chronic LD treatment on metabolism, blood flow and blood-brain barrier permeability in the 6-OHDA rat model
- 12:00pm-1:30pm
-
Impact of datscan on clinical decision making: diagnosis and management of clinically uncertain Parkinsonian syndromes
- 12:00pm-1:30pm
-
Impact of sociodemographic and clinical characteristics on cognition of individuals with Parkinson’s disease
- 12:00pm-1:30pm
-
Impaired cube copy on the MOCA indicates worse performance in several cognitive domains in Parkinson´s disease
- 12:00pm-1:30pm
-
Impairment of decision-making processes in patients with Parkinson’s disease during a strategic game
- 12:00pm-1:30pm
-
Impulse control disorder in Parkinson’s disease is not related to lower cognitive performance
- 12:00pm-1:30pm
-
Impulsive action tendencies in GPi DBS Parkinson’s patients
- 12:00pm-1:30pm
-
Impulsive-compulsive behaviors in patients with Parkinson’s disease and demographically-comparable group of healthy controls
- 12:00pm-1:30pm
-
In vivo MRI detection of Parkinson’s disease associated degeneration in the lateral ventral tier of substantia nigra pars compacta
- 12:00pm-1:30pm
-
Increased cortical control of gait in patients with Parkinson’s disease and freezing of gait
- 12:00pm-1:30pm
-
Increasing placebo response in Parkinson’s disease through apomorphine pre-conditioning
- 12:00pm-1:30pm
-
Independent validation of the quality of life in essential tremor questionnaire (QUEST)
- 12:00pm-1:30pm
-
Indirect comparison of tolerability of deutetrabenazine and tetrabenazine in the FIRST-HD and TETRA-HD trials
- 12:00pm-1:30pm
-
Inferring the causal interplay of motor related brain areas in the aging brain: A dynamic causal modeling (DCM) approach
- 12:00pm-1:30pm
-
Inferring the coupling of motor related brain areas during paced finger tapping in Parkinson’s patients
- 12:00pm-1:30pm
-
Instrumented quantitative study of movement and gait in Parkinson’s disease clinical subtypes
- 12:00pm-1:30pm
-
Interrelation between gait impairment with cognitive disturbances in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Intraoperative localization of beta band and high-frequency oscillations within the subthalamic nucleus
- 12:00pm-1:30pm
-
Investigating the relationship between reaction time and cognition in Parkinson’s disease
- 12:00pm-1:30pm
-
Investigation of driving ability to drive safely in patients with Parkinson’s disease by interview
- 12:00pm-1:30pm
-
Iron accumulation and volume loss in the extrapyramidal motor system in Friedreich ataxia: The IMAGE-FRDA study
- 12:00pm-1:30pm
-
Iron accumulation in a Wilson disease patient: Longitudinal 7T MRI and transcranial sonography study
- 12:00pm-1:30pm
-
Is it just a coincidence? Three new cases of Parkinson’s disease associated with myasthenia gravis
- 12:00pm-1:30pm
-
Is the defective gait automaticity associated to deficiencies in implicit learning in patients with Parkinson’s disease?
- 12:00pm-1:30pm
-
Is the selection of stepping impaired in PD in ON state?
- 12:00pm-1:30pm
-
Isolated micrographia following stroke
- 12:00pm-1:30pm
-
Levodopa impairs learning in healthy young adults: Implications for Parkinson’s disease
- 12:00pm-1:30pm
-
Levodopa induced dyskinesia and nicotinergic α4β2 acetylcholin receptor density: A multi-tracer imaging study
- 12:00pm-1:30pm
-
Long-term impact of lead poisoning on neurologic function in children and adolescents
- 12:00pm-1:30pm
-
Longterm outcome of cognition following subthalamic deep brain stimulation in Parkinson´s disease
- 12:00pm-1:30pm
-
Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington’s disease gene carriers
- 12:00pm-1:30pm
-
Maintenance of balance function in patients with HD treated with deutetrabenazine, as measured by Berg balance test (BBT) in First-HD
- 12:00pm-1:30pm
-
Manual MRI morphometry in Parkinsonian syndromes
- 12:00pm-1:30pm
-
May substantia nigra volume asymmetry be an indicator of motor asymmetry in Parkinson’s disease? A retrospective analysis
- 12:00pm-1:30pm
-
Metabolic brain changes related to specific cognitive impairment in non-demented Parkinson’s disease patients
- 12:00pm-1:30pm
-
MMSE and MoCA feasibility in Parkinson’s disease and dementia with Lewy bodies: A multicenter 1-year follow-up study
- 12:00pm-1:30pm
-
Modulation of local field potentials during gait in the STN of patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Monoaminergic biomarkers of cognitive decline in Parkinson’s disease and Lewy body dementia
- 12:00pm-1:30pm
-
Motor function restoration during REM sleep behavioral disorder in Parkinson’s disease: A vídeo-polysomnography study
- 12:00pm-1:30pm
-
Motor subtypes in Parkinson’s disease are distinguished by alterations in morphology and white matter integrity
- 12:00pm-1:30pm
-
Movement disorders are the common signs as the first neurological deficit in cases with spinocerebellar ataxia type 2 (SCA2)
- 12:00pm-1:30pm
-
Movement disorders in diabetes – Report of two cases
- 12:00pm-1:30pm
-
Movement execution but not preparation modulates somatosensory temporal discrimination thresholds in healthy subjects
- 12:00pm-1:30pm
-
Movement related beta oscillatory activity during self-paced wrist movement in the human subthalamic nucleus
- 12:00pm-1:30pm
-
MRI signatures of the brain of Parkinson’s disease and idiopathic REM sleep behavioral disorder subjects
- 12:00pm-1:30pm
-
Multicenter report of clinical use of a non-motor symptom questionnaire for craniocervical dystonia: The DNMS quest
- 12:00pm-1:30pm
-
Multimodal imaging assessment of nigrostriatal pathway in Parkinson’s disease using 11C-PE2I PET and neuromelanin-sensitive MR
- 12:00pm-1:30pm
-
Natural history of saccadic abnormalities in spinocerebellar ataxia 2: Implications to designing future clinical trials
- 12:00pm-1:30pm
-
Neural mechanisms underlying step initiation failure in patients with Parkinson’s disease and freezing of gait
- 12:00pm-1:30pm
-
Neural substrates of excessive daytime sleepiness in early drug naïve Parkinson’s disease: A resting state functional MRI study
- 12:00pm-1:30pm
-
Neuroanatomical correlates of apathy in non-demented and non-depressed Parkinson’s disease
- 12:00pm-1:30pm
-
Neuromelanin in Parkinson’s disease: A 3 T MRI study
- 12:00pm-1:30pm
-
Neuropsychiatric, personality and non-motor correlates of impulse control disorders in recent onset Parkinson’s disease
- 12:00pm-1:30pm
-
Neuropsychological correlates of impulse control disorders and punding in Parkinson´ s disease
- 12:00pm-1:30pm
-
Neuropsychological subgroups in non-demented Parkinson’s disease: A latent class analysis
- 12:00pm-1:30pm
-
Neuropsychology and magnetic resonance correlation in Parkinson´s disease mild cognitive impairment: Case-control study
- 12:00pm-1:30pm
-
Nigrostriatal degeneration and serum BDNF levels in patients with “de novo” untreated Parkinson’s disease
- 12:00pm-1:30pm
-
Olfaction analysis in spinocerebellar ataxia type 10 and type 3 comparing with healthy controls and PD
- 12:00pm-1:30pm
-
Olfactory performance and resting state functional connectivity in non-demented drug naïve patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Optogenetic silencing of locus coeruleus activity in mice impairs cognitive flexibility in an attentional set-shifting task
- 12:00pm-1:30pm
-
Pantotenate kinase associated neurodegeneration (PKAN): Proposal for a clinical rating scale
- 12:00pm-1:30pm
-
Parkinson’s disease patients with onset in right side have a worse cognitive prognosis
- 12:00pm-1:30pm
-
Parkinson’s disease-linked mutation in DNAJC13 causes specific trafficking defect in endosomal pathway
- 12:00pm-1:30pm
-
Perception of time in music in Parkinson´s disease – Processing of musical syntax compensates rhythmic deficits
- 12:00pm-1:30pm
-
Performance in Montreal cognitive assessment and functional independence in Parkinsonian with normal mini-mental state examination
- 12:00pm-1:30pm
-
Peripheral insulin sensitivity and body composition alterations in early stage Machado Joseph disease
- 12:00pm-1:30pm
-
Phenomenology and therapeutic strategies in a series of patients with chorea-acanthocytosis
- 12:00pm-1:30pm
-
Phenotypic insights into ADCY5-associated disease
- 12:00pm-1:30pm
-
Phenotypic spectrum and longitudinal outcome of Parkinson’s disease patients with psychosis
- 12:00pm-1:30pm
-
Pisa syndrome in a drug-naive Parkinson’s disease patient
- 12:00pm-1:30pm
-
Plasma ceramides and glucosylceramides predict cognitive decline among cognitively normal Parkinson’s disease patients
- 12:00pm-1:30pm
-
Predicting incident impulse control disorder behaviour in Parkinson’s disease patients using a clinical-genetic model
- 12:00pm-1:30pm
-
Predictive performance of EEG theta spectral power over developing dementia in Parkinson’s disease
- 12:00pm-1:30pm
-
Predictors of quality of life in Huntington’s disease. A longitudinal observational study
- 12:00pm-1:30pm
-
Predictors of recurrent falls in people with Parkinson’s disease and development of a predictive tool
- 12:00pm-1:30pm
-
Prevalence of depression and dementia in Parkinson’s disease
- 12:00pm-1:30pm
-
Prevalence of depression in Parkinson’s disease patients
- 12:00pm-1:30pm
-
Prodromal criteria of spinocerebellar type 2: Lessons for physiopathology, natural history and therapeutical trials
- 12:00pm-1:30pm
-
Profile of depressive symptoms in Parkinson’s disease patients and a population-based elderly cohort
- 12:00pm-1:30pm
-
Prognostic factors of motor symptoms in Parkinson’s disease using neuromelanin imaging and the relationship with (123)I-FP-CIT-SPECT
- 12:00pm-1:30pm
-
Program evaluation empowerment of people with Huntington’s disease (HD) and their families: Using goal attainment scaling (GAS)
- 12:00pm-1:30pm
-
Progressive ataxia and palatal tremor: A case report
- 12:00pm-1:30pm
-
Prolonged cerebellar syndrome after Legionnaire’s disease
- 12:00pm-1:30pm
-
Psychogenic movement disorder in cerebellar atrophy
- 12:00pm-1:30pm
-
Psychosis in Huntington’s disease
- 12:00pm-1:30pm
-
Quantifiable changes in cortical visual processing in patients with Parkinson’s disease but no cognitive impairment
- 12:00pm-1:30pm
-
Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease
- 12:00pm-1:30pm
-
Recruitment of single subthalamic neurons for kinematic control of hand and feet movements employs different strategies
- 12:00pm-1:30pm
-
Refined basal ganglia model accounting for GPi modulation of thalamic tonic and burst modes
- 12:00pm-1:30pm
-
Relationship of MDS-UPDRS non-motor symptoms to cognitive functioning in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Reliability of a newly developed protocol for fiberoptic endoscopic evaluation of swallowing in Parkinson’s patients (PARK-FEES)
- 12:00pm-1:30pm
-
Reliability of verbal and written trail test for individuals with Parkinson’s disease: Is it a good cognitive test?
- 12:00pm-1:30pm
-
Repeat size and X-inactivation in the clinical phenotype of fragile X premutation carrier sisters: A familial case series
- 12:00pm-1:30pm
-
Research of vestibular evoked myogenic potentials (VEMP) in the diagnosis of postural instability in Parkinson’s disease
- 12:00pm-1:30pm
-
Response inhibition in Parkinson’s disease
- 12:00pm-1:30pm
-
Resting state functional connectivity in olfactory network in de novo Parkinson’s disease
- 12:00pm-1:30pm
-
Resting-state functional connectivity of subthalamic nucleus in different phenotypes of Parkinson’s disease
- 12:00pm-1:30pm
-
Retrieval action verbs is impaired in Parkinson´s disease patients using a sentence completion task
- 12:00pm-1:30pm
-
Selective activation of excitatory cell groups in the medial medulla differentially affects spatial-temporal gait parameters
- 12:00pm-1:30pm
-
Self-perception of daily performance in relation to motor performance in advanced Parkinson’s disease – Case studies
- 12:00pm-1:30pm
-
Self-reported cognitive complaints and neuropsychological performance in idiopathic REM sleep behavior disorder
- 12:00pm-1:30pm
-
Severe striatal and pallidal atrophy in early disease stages of X-linked dystonia-parkinsonism
- 12:00pm-1:30pm
-
Shape and volume abnormalities relate to motor abilities in idiopathic rapid eye movement sleep behavior disorder
- 12:00pm-1:30pm
-
Single unit activity of globus pallidus during voluntary movements in patients with cervical dystonia
- 12:00pm-1:30pm
-
Single unit activity of medial thalamus during goal-directed motor and cognitive behavior in patients with cervical dystonia
- 12:00pm-1:30pm
-
Social cognition assessment in progressive supranuclear palsy: The cognitive interface with frontotemporal dementia
- 12:00pm-1:30pm
-
Specific in-patient’s rehabilitation improves postural and gait instability in Huntington’s disease
- 12:00pm-1:30pm
-
Spectral analysis of rapid eye movement (REM) sleep as a potential marker of neurodegenerative disease in REM sleep behavior disorder
- 12:00pm-1:30pm
-
Spinocerebellar ataxia 17: First observation in Russia
- 12:00pm-1:30pm
-
Sporadic cerebellar ataxia associated with hypogonadotropic hypogonadism and PNPLA6 gene mutation. Case report in a Brazilian patient
- 12:00pm-1:30pm
-
Stage dependent alteration of cortical excitability in patients with hepatic encephalopathy
- 12:00pm-1:30pm
-
Staging of cognitive impairment: Validation of a novel cognitive score with [18F]FDG-PET
- 12:00pm-1:30pm
-
Strategies for a high quality data in an observational longitudinal study: Enroll-HD experience
- 12:00pm-1:30pm
-
Striatal molecular alterations in Huntington’s disease gene expansion carriers: A systematic review and meta-analysis of PET studies
- 12:00pm-1:30pm
-
STUB1/CHIP mutations cause Gordon Holmes syndrome as part of widespread multisystemic neurodegeneration: Evidence from novel mutations
- 12:00pm-1:30pm
-
Study of striatal dopamine transporter function in Alzheimer’s disease with parkinsonism
- 12:00pm-1:30pm
-
Sub-acute rapidly progressive cerebellar ataxia – A case of JC virus associated granule cell neuronopathy (GCN)
- 12:00pm-1:30pm
-
Subthalamic neurons encode reward hypersensitivity and loss hyposensitivity in Parkinson’s patients with impulse control disorders
- 12:00pm-1:30pm
-
Suppression of dyskinesia in Parkinson’s disease by electrical stimulation of dorsal subthalamic nucleus tissue
- 12:00pm-1:30pm
-
Symptom progression in a large cohort of Parkinson’s disease cases in a clinical practice setting
- 12:00pm-1:30pm
-
Synaptic biomarkers for cognitive decline in Lewy body dementias and Alzheimer’s disease. A mass spectrometry approach
- 12:00pm-1:30pm
-
Tau PET in Parkinson syndromes. A new diagnostic tool?
- 12:00pm-1:30pm
-
Technology use and impulse control disorders (ICDs) in patients with Parkinson’s disease (PD)
- 12:00pm-1:30pm
-
Temporal working memory deficit in Parkinson’s disease
- 12:00pm-1:30pm
-
Testing candidate transcriptional biomarkers of asymtpomatic and symptomatic stages in spinocerebellar ataxia type 3 (SCA3)
- 12:00pm-1:30pm
-
The aetiology of idiopathic late onset cerebellar ataxia
- 12:00pm-1:30pm
-
The alterations in behavioral memory for prolongation disease duration in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
The assessment of quality of life in patients with early and moderately advanced Huntington disease
- 12:00pm-1:30pm
-
The association between structural brain connectivity with plasma APO-A1 levels in Parkinson’s disease: Connectometry approach
- 12:00pm-1:30pm
-
The cerebral structural and functional signatures of impulse control disorder in Parkinson’s disease
- 12:00pm-1:30pm
-
The clinical characteristics of Lewy body disease showed autonomic failures preceding motor signs
- 12:00pm-1:30pm
-
The clinical significance of brain microbleed in Alzheimer’s disease patients with Parkinsonian signs
- 12:00pm-1:30pm
-
The dopamine agonist withdrawal syndrome rating scale (DAWS-RS): Initial development of a new non-motor scale
- 12:00pm-1:30pm
-
The effect of an eight-week mindfulness training intervention on emotion related brain activation in people with Parkinson’s disease
- 12:00pm-1:30pm
-
The effect of dopamine on global versus specific inhibitory control in Parkinson’s disease
- 12:00pm-1:30pm
-
The effect of dopaminergic therapy on stimulus-response learning and decision-making in Parkinson’s disease using fMRI
- 12:00pm-1:30pm
-
The effect of statin use on cognition in Parkinson’s disease
- 12:00pm-1:30pm
-
The effects of gait and balance training on walking economy in early and mid stage Huntington’s disease
- 12:00pm-1:30pm
-
The efficacy of quantitative 99mTc-TRODAT-1 SPECT in diagnosis of aged patients with Parkinson’s disease
- 12:00pm-1:30pm
-
The evaluation of metabolic differences by using 18F-FDG-PET/CT in demented and non demented Idiophatic Parkinson’s disease patients
- 12:00pm-1:30pm
-
The feasibility of measuring fatigability in early-stage Parkinson’s disease using functional MRI
- 12:00pm-1:30pm
-
The interactive walkway: Towards assessing gait-environment interactions in a clinical setting
- 12:00pm-1:30pm
-
The movement disorder associated with NMDAR-antibody encephalitis: An expert-rater video study
- 12:00pm-1:30pm
-
The nucleocytoplasmic transport of ataxin-3 as pathogenic mechanism in spinocerebellar ataxia type 3
- 12:00pm-1:30pm
-
The patterns of olfactory function in Parksinson’s disease patients with mild cognitive impairment
- 12:00pm-1:30pm
-
The position of the conus medullaris and the prevalence of isolated lipoma of filum terminale in Parkinson’s disease
- 12:00pm-1:30pm
-
The practicalities of freezing of gait assessment methods
- 12:00pm-1:30pm
-
The pull test in healthy subjects: Quantitative, posturographic and electromyographic analysis
- 12:00pm-1:30pm
-
The regulation of ASIC1a on dopamine release and its implication in the pathogenesis of Parkinson’s disease
- 12:00pm-1:30pm
-
The relationship among clinical features, DAT scintigraphy and MIBG cardiac scintigraphy in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
The relationship between cognitive task and postural stability in the early stages of Parkinson’s disease
- 12:00pm-1:30pm
-
The relationship between impulse control disorders and dyskinesia in Parkinson´s disease: The ALTHEA study
- 12:00pm-1:30pm
-
The role of cathepsin L involved in the activation of microglia and Parkinson’s disease
- 12:00pm-1:30pm
-
The role of depression in suicidal ideation in a sample of patients with Parkinson’s disease
- 12:00pm-1:30pm
-
The role of striatal dopaminergic terminals in early de novo PD patients with speech impairment
- 12:00pm-1:30pm
-
The role of the frontal lobe in complex walking among healthy older adults and patients with Parkinson’s disease: An fNIRS study
- 12:00pm-1:30pm
-
The scale for assessment and rating of ataxia in early onset ataxia; always a reliable biomarker?
- 12:00pm-1:30pm
-
The spectrum of abnormal movements and predictors of outcome in anti-NMDA receptor encephalitis in Thai patients
- 12:00pm-1:30pm
-
THK-5351 tau-tracer uptake in patients with clinically diagnosed progressive supranuclear palsy
- 12:00pm-1:30pm
-
Tracking Parkinson’s disease over 2-6 years with MRI
- 12:00pm-1:30pm
-
Tractography study of individuals with mutation for Huntington’s disease in symptomatic and pre-symptomatic phases
- 12:00pm-1:30pm
-
Transcranial sonography of the substantia nigra and its correlation with iron metabolism and c-reactive protein in Parkinson’s disease
- 12:00pm-1:30pm
-
Transient hemiballismus in a fast jet pilot
- 12:00pm-1:30pm
-
Treatment and diagnosis with the use of neuropsychological scale in patients with posttraumatic subcortical Parkinsonian dementia
- 12:00pm-1:30pm
-
Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia
- 12:00pm-1:30pm
-
Ultra high field magnetic resonance imaging of nigrosome 1 is a biomarker of new onset and premotor Parkinson’s disease
- 12:00pm-1:30pm
-
Unilateral subthalamotomy in Parkinson´s disease: Cognitive and neuropsychiatric effects and correlation with lesion size
- 12:00pm-1:30pm
-
Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination
- 12:00pm-1:30pm
-
Utility of the Mayo sleep questionnaire in predicting final autopsy diagnosis of alpha-synucleinopathy
- 12:00pm-1:30pm
-
Validation of the Seoul-instrumental activity of daily living in the detection of dementia in Parkinson’s disease
- 12:00pm-1:30pm
-
Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT)
- 12:00pm-1:30pm
-
Verbatim patient-reported outcomes and trails making test B (TMT-B) performance in the REACH2HD trial
- 12:00pm-1:30pm
-
Vestibular evoked myogenic potentials as biomarkers for non-motor symptoms of Parkinson’s disease
- 12:00pm-1:30pm
-
Visual hallucinations and executive dysfunction in Charles Bonnet syndrome: Preliminary findings from SHAPED
- 12:00pm-1:30pm
-
Visual hallucinations may serve as a possible predictor for Parkinson’s disease dementia
- 12:00pm-1:30pm
-
Visual vs. automated analysis of [123I]FP-CIT SPECT scans in patients with parkinsonism
- 12:00pm-1:30pm
-
Volition and action control in Parkinson’s disease patients with impulsive-compulsive behaviour disorders
- 12:00pm-1:30pm
-
Volumetry of the olfactory bulbs and tracts in the differential diagnosis of neurodegenerative parkinsonisms
- 12:00pm-1:30pm
-
What predicts Parkinson’s disease? Hyposmia, MIBG SPECT, DAT SPECT and the PD-specific metabolic pattern
- 12:00pm-1:30pm
-
“Words untold”
- 12:00pm-1:30pm
-
A case of hemifacial spasm with a right-sided pontine meningioma that resolved with PICA loop vascular decompression surgery
- 12:00pm-1:30pm
-
A case with posttraumatic functional shoulder dyskinesia
- 12:00pm-1:30pm
-
A clinical trials ‘charter’ to improve communication about, recruitment to and retention in Parkinson’s clinical trials
- 12:00pm-1:30pm
-
A combined therapeutic approach in the management of abnormal postures in Parkinson’s disease
- 12:00pm-1:30pm
-
A community organizing approach to identify and address the barriers to healthcare for XDP patients in Panay Island, Philippines
- 12:00pm-1:30pm
-
A comparison of deep brain stimulation and continuous intrajejunal levodopa infusion in advanced Parkinson’s disease: The INVEST study
- 12:00pm-1:30pm
-
A double-blind randomized controlled trial of cognitive training for freezing of gait in Parkinson’s disease
- 12:00pm-1:30pm
-
A dynamic causal model of the superior colliculus: Inhibitory activity increases with the temporal discrimination threshold
- 12:00pm-1:30pm
-
A heterozygous splicing mutation c.823-10G>T at the intron9/exon 10 of the MAPT gene in an Irish family with FTDP- 17
- 12:00pm-1:30pm
-
A multi-centre European comparative survey of advanced therapies (infusion and deep brain stimulation) in Parkinson’s disease
- 12:00pm-1:30pm
-
A new test for the measuring hand functions in Parkinson’s disease: Psychometric evaluation of the squares test
- 12:00pm-1:30pm
-
A randomized clinical trial of atomoxetine treatment for mild cognitive impairment (MCI) in Parkinson’s disease (PD)
- 12:00pm-1:30pm
-
A rapid chemical-genetic screen utilising impaired movement phenotypes in caenorhabditis elegans
- 12:00pm-1:30pm
-
A survey of impulse control disorders in Chinese patients with Parkinson’s disease and literature review
- 12:00pm-1:30pm
-
Abnormal motor sequence representation in dystonia
- 12:00pm-1:30pm
-
AbobotulinumtoxinA for cervical dystonia: A meta-analysis of injection practices across 5 countries
- 12:00pm-1:30pm
-
Activities of daily living and motor scores of the UPDRS in fluctuating Parkinson’s disease patients treated with opicapone
- 12:00pm-1:30pm
-
Acute movement disorders in Tunisian childhood
- 12:00pm-1:30pm
-
ADCY5 screening in paediatric-onset hyperkinetic movement disorders: Report of three new Italian families
- 12:00pm-1:30pm
-
Adenosine A2A receptor antagonist istradefylline might have efficacy to fatigue and depression in some patients of Parkinson’s disease
- 12:00pm-1:30pm
-
ADS-5102 (amantadine HCl) extended-release capsules reduced levodopa-induced dyskinesia in the phase 3 EASE LID study
- 12:00pm-1:30pm
-
Alternating hemiplegia of childhood: Movement disorders and epilepsy due to mutuations in ATP1A3
- 12:00pm-1:30pm
-
AMP kinase regulates ligand-gated K-ATP channels in substantia nigra dopamine neurons
- 12:00pm-1:30pm
-
An ongoing phase 2, multi-centre, open-label, study of WTX101 in Wilson disease patients – Early observations
- 12:00pm-1:30pm
-
An update on genotype-phenotype correlation in X-linked dystonia-parkinsonism (XDP/DYT3)
- 12:00pm-1:30pm
-
AntiParkinsonian effects of the “radiprodil and tozadenant” combination in MPTP-treated marmosets
- 12:00pm-1:30pm
-
AntiParkinsonian treatment patterns and motor complications among patients with Parkinson´s disease in Estonia
- 12:00pm-1:30pm
-
Apraclonidine in blepharospasm
- 12:00pm-1:30pm
-
Apraclonidine in the treatment of ptosis
- 12:00pm-1:30pm
-
Are Parkinson’s disease futility studies futile?
- 12:00pm-1:30pm
-
Are we speaking the same language? A pilot study to evaluate the agreement in clinical phenotyping of children with cerebral palsy
- 12:00pm-1:30pm
-
Assessing vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment
- 12:00pm-1:30pm
-
Assessment of need for treatment with botulinum toxin type A in cervical dystonia patients
- 12:00pm-1:30pm
-
Assessment of oral hygiene status before and after the use of powered tooth brush in patients with Parkinson’s diseases
- 12:00pm-1:30pm
-
Association analysis of NALCN polymorphisms rs1338041 and rs61973742 in a Chinese population with isolated cervical dystonia
- 12:00pm-1:30pm
-
Association of Parkinson’s disease with essential tremor
- 12:00pm-1:30pm
-
Association of the DRD2 (CA) n and DRD3 Ser9Gly polymorphisms with Parkinson’s disease and response of dopamine agonists
- 12:00pm-1:30pm
-
Atypical presentation of psychogenic movement disorder with jaw-opening dystonia: Two cases reports
- 12:00pm-1:30pm
-
Autophagic modulation by rosuvastatin prevent rotenone induced neurotoxicity as an in vitro model of Parkinson’s disease
- 12:00pm-1:30pm
-
Balance and gait disturbances in Parkinson’s disease patients with falls and freezing of gait
- 12:00pm-1:30pm
-
Balance training in individual’s with Parkinson’s disease: Therapist-supervised vs. home-based exercise programmes
- 12:00pm-1:30pm
-
Beta – blockers worsen vascular parkinsonism in patients with concomitant coronary heart disease
- 12:00pm-1:30pm
-
Beyond 30 years of Parkinson’s disease: A comprehensive characterization of long-surviving patients
- 12:00pm-1:30pm
-
Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Biseptol a new antiParkinsonian agent?
- 12:00pm-1:30pm
-
Blindfolded balance training in patients with Parkinson’s disease: A sensory-motor strategy to improve the gait
- 12:00pm-1:30pm
-
Body position during sleep in patients with Parkinson’s disease (PD): A sensor-based analysis
- 12:00pm-1:30pm
-
Botulinum neurotoxins type A versus B for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update
- 12:00pm-1:30pm
-
Botulinum toxin in cerebral palsy children with gait disorder: Different therapy approaches
- 12:00pm-1:30pm
-
Botulinum toxin type A therapy for blepharospasm – Update of a Cochrane systematic review and meta-analysis
- 12:00pm-1:30pm
-
Botulinum toxin type B therapy for cervical dystonia – 2015 update of a Cochrane systematic review and meta-analysis
- 12:00pm-1:30pm
-
Brain networks revealed by resting state functional MRI in familial and sporadic primary dystonia
- 12:00pm-1:30pm
-
Can hospital admissions predict mortality in Parkinson’s?
- 12:00pm-1:30pm
-
Cervical dystonia and quality of life
- 12:00pm-1:30pm
-
Cervical dystonia associated to Wallenberg syndrome
- 12:00pm-1:30pm
-
Cervical dystonia preceding Parkinson´s disease – Continuum – coincidence or epiphenomenon–Report of 3 cases
- 12:00pm-1:30pm
-
Changes in handwriting following repetitive transcranial magnetic stimulation over pre-motor cortex in Parkinson’s disease
- 12:00pm-1:30pm
-
Characterization of European longitudinal cohort studies in Parkinson’s disease – Report of the JPND working group BioLoC-PD
- 12:00pm-1:30pm
-
Chewing-induced blepharospasm in Parkinson’s disease
- 12:00pm-1:30pm
-
Classification and recommendation of nonpharmacological therapies for Parkinson’s disease
- 12:00pm-1:30pm
-
Clinical and biological predictors of time to initiation of symptomatic therapy in early Parkinson’s disease
- 12:00pm-1:30pm
-
Clinical course and treatment of 6 children with GNAO1 mutations causing a severe, life-threatening chorea
- 12:00pm-1:30pm
-
Clinical effect and dose conversion of rytary (numient) in 50 consecutive patients with PD motor fluctuations
- 12:00pm-1:30pm
-
Clinical effects of pallidal stimulation in dystonia are quantitatively related to intracortical inhibition
- 12:00pm-1:30pm
-
Clinical outcomes of pallidal and subthalamic nucleus deep brain stimulation in isolated cranial and cranio-cervical dystonia
- 12:00pm-1:30pm
-
Clinical profile of patients with writer’s cramp
- 12:00pm-1:30pm
-
Cognitive behavioural thrapy and adiunctive physical therapy for functional movement disorders
- 12:00pm-1:30pm
-
Combined pallidal and thalamic stimulation for multifocal primary dystonia with prominent writers’ cramp
- 12:00pm-1:30pm
-
Conjugal Parkinson´s disease – Real or chance?
- 12:00pm-1:30pm
-
Continuous subcutaneous delivery of solubilized carbidopa improves the pharmacokinetic profile of levodopa
- 12:00pm-1:30pm
-
Conversion to IPX066, extended-release carbidopa-levodopa, in advanced Parkinson’s disease patients: Dosing patterns
- 12:00pm-1:30pm
-
Copper chelation efficacy of alginate/chitosan based D-penicillamine nanoparticles in rat model of non-Wilsonian brain copper toxicosis
- 12:00pm-1:30pm
-
Correlation between Parkinson’s disease and malignant tumors
- 12:00pm-1:30pm
-
Creutzfeldt-Jakob disease presenting predominantly with movement disorder: A case report
- 12:00pm-1:30pm
-
Critical path for Parkinson’s, I: Data sharing and regulatory science in catalyzing innovation for Parkinson’s disease
- 12:00pm-1:30pm
-
CSF level of chromogranin A in amyotrophic lateral sclerosis
- 12:00pm-1:30pm
-
Development of a human neuroblastoma model of pantothenate kinase-associated neurodegeneration
- 12:00pm-1:30pm
-
Diaphragmatic dystonia in a patient that presents with Meige syndrome and disordered breathing
- 12:00pm-1:30pm
-
Differences in physicians’ understanding of biologic and biosimilar medicines in the USA and Europe
- 12:00pm-1:30pm
-
Differential clinical outcomes in unifocal vs. multifocal premotor rTMS for Parkinson’s disease: A randomized trial
- 12:00pm-1:30pm
-
Differential effects of tango, treadmill, and stretching interventions on gait in people with Parkinson’s disease
- 12:00pm-1:30pm
-
Digitally captured Archimedes spiral indices correlate with clinical assessment of dystonia severity
- 12:00pm-1:30pm
-
DIRECT DBS: A prospective, multi-center clinical trial with blinding for a directional DBS lead
- 12:00pm-1:30pm
-
Disruption of cerebellar connectivity in cervical dystonia
- 12:00pm-1:30pm
-
Distinguishing pseudo-dystonia from dystonia: A case series
- 12:00pm-1:30pm
-
Diurnal variation of levodopa plasma concentration in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Diverse effects of alpha-synuclein fibrils on various neuron cell lines, using different buffers
- 12:00pm-1:30pm
-
Do predictors of good response to deep brain stimulation in primary cervical movement disorders exist?
- 12:00pm-1:30pm
-
Does distance walked after two minutes predict total 6 minute walk test distance in people with Parkinson’s disease?
- 12:00pm-1:30pm
-
Does physical exercise influence the cognitive domains that predict dementia in Parkinson’s disease?
- 12:00pm-1:30pm
-
Dopamine dysregulation syndrome /DDS/ in LCIG infusion: Successful treatment without interrupting the pump therapy
- 12:00pm-1:30pm
-
Dopaminergic medicines are alternative drugs for treatment of motor disorders in ischemic stroke
- 12:00pm-1:30pm
-
Dosing of abobotulinumtoxinA and muscle selection in patients with simple patterns of cervical dystonia
- 12:00pm-1:30pm
-
Drug safety in the pharmacotherapy of Parkinson’s disease
- 12:00pm-1:30pm
-
Duloxetine, a serotonin and norepinephrine reuptake inhibitor, reduces daily OFF time in Parkinson’s disease
- 12:00pm-1:30pm
-
Duodopa treatment experience in Oradea
- 12:00pm-1:30pm
-
Duration of levodopa treatment and prevalence of osteoporosis in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Dynamic prediction for multiple repeated measures and event time data: An application to Parkinson’s disease
- 12:00pm-1:30pm
-
Dystonia-deafness syndrome caused by beta -actin gene mutation and the effect of pallidal deep brain stimulation
- 12:00pm-1:30pm
-
Dystonia, myoclonus, and tremor without epilepsy associated with a mutation in STXBP1
- 12:00pm-1:30pm
-
Dystonia, tremor, and dystonic tremor
- 12:00pm-1:30pm
-
DYT16/PRKRA founder mutation causes childhood-onset generalized dystonia in a family from southern Italy
- 12:00pm-1:30pm
-
DYT2 dystonia – Too rare to be found?
- 12:00pm-1:30pm
-
Early retirement and loss of income among X linked dystonia parkinsonism (XDP / DYT3) patients in Capiz, Roxas City Philippines
- 12:00pm-1:30pm
-
ECG-based cardiopulmonary coupling for sleep stability assessment in patients with amyotrophic lateral sclerosis
- 12:00pm-1:30pm
-
Effect of dopamine and L-3,4 – dihydroxyphenylalanine in treatment of experimental parkinsonism
- 12:00pm-1:30pm
-
Effect of nelotanserin on objective sleep parameters in a phase 2 study in patients with insomnia
- 12:00pm-1:30pm
-
Effect of outside influences on the therapeutic benefits of botulinum toxin injections
- 12:00pm-1:30pm
-
Effect of pharmacist-led interventions on motor symptoms and quality of life in Parkinson’s patients: A pilot study
- 12:00pm-1:30pm
-
Effect of repeated intravenous amantadine infusions in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Effect of right DLPFC-repetitive transcranial magnetic stimulation (rTMS) on tardive dyskinesia in patients with psychosis
- 12:00pm-1:30pm
-
Effectiveness of Lee Silverman voice treatment big on improving gait and quality of life in Parkinson’s disease patients after STN-DBS
- 12:00pm-1:30pm
-
Effects of cerebellar theta-burst stimulation on arm and neck movement kinematics in patients with focal dystonia
- 12:00pm-1:30pm
-
Effects of combined repetitive transcranial magnetic stimulation and treadmill training on gait performance in Parkinson’s disease
- 12:00pm-1:30pm
-
Effects of levodopa on adaptation of reactive stepping in people with Parkinson’s disease
- 12:00pm-1:30pm
-
Effects of movement rate and amplitude on repetitive finger motion in people with Parkinson’s disease and freezing of gait
- 12:00pm-1:30pm
-
Effects of nilotinib on safety in open-label phase I clinical trial in Parkinson’s disease with dementia and Lewy body dementia
- 12:00pm-1:30pm
-
Effects of pyridostigmine bromide vs. fludrocortison in the treatment of orthostatic hypotension in Parkinson’s disease
- 12:00pm-1:30pm
-
Effects of safinamide in patients with Parkinson’s disease measured by Parkinson’s KinetiGraphTM
- 12:00pm-1:30pm
-
Effects of the biodex stability system training on balance, gait and fatigue in Parkinson’s disease
- 12:00pm-1:30pm
-
Effects of videogame step training on gait adaptability in people with Parkinson´s disease – A randomized controlled trial
- 12:00pm-1:30pm
-
Efficacy and safety of abobotulinumtoxinA in craniocervical dystonia and hemifacial spasm
- 12:00pm-1:30pm
-
Efficacy and safety of tetrabenazine in hyperkinetic movements disorders- An observational study
- 12:00pm-1:30pm
-
Efficacy of 4845 botulinum toxin (BoNT) treatment cycles, and clinical strategies after a failed cycle
- 12:00pm-1:30pm
-
Efficacy of apomorphine subcutaneous injections in patients with levodopa dose failures and morning akinesia
- 12:00pm-1:30pm
-
Efficiency of carotid endarterectomy in vascular parkinsonism in patients with stenotic carotid artery disease
- 12:00pm-1:30pm
-
Eight weeks of home-based balance training not as effective as therapist-based during dual tasks
- 12:00pm-1:30pm
-
Elemental profiles as biomarkers for diagnosis and disease progression of Parkinson’s disease
- 12:00pm-1:30pm
-
Epidemiological and clinical profile of essential blepharospasm and its response to treatment with TBA over a 11-year period
- 12:00pm-1:30pm
-
Epidemiological investigation of yips among Golfers in Japan
- 12:00pm-1:30pm
-
Establishment of InMotion, an independent, fee-free community center for persons with movement disorders
- 12:00pm-1:30pm
-
European physiotherapy guideline for Parkinson’s disease: Information for neurologists
- 12:00pm-1:30pm
-
Evaluation of impulse control disorders in fluctuating Parkinson’s disease patients under opicapone treatment
- 12:00pm-1:30pm
-
Examining the clinical profile of nelotanserin, a novel agent in development for Lewy body dementia
- 12:00pm-1:30pm
-
Exercise-induced adaptive neuroplasticity in the MPTP mouse model of Parkinson’s disease
- 12:00pm-1:30pm
-
Exome sequencing reveals homozygous mutations in SACS, ATCAY, and MCOLN1 in three Pakistani families with complex dystonia
- 12:00pm-1:30pm
-
Experience of pallidal deep brain stimulation (DBS) in dystonia at a tertiary care centre in India
- 12:00pm-1:30pm
-
Expiratory muscle training for the impaired loudness of speech in Parkinson’s disease: An open-label study
- 12:00pm-1:30pm
-
Exploratory efficacy of opicapone in fluctuating Parkinson’s disease patients at different stages of symptom progression
- 12:00pm-1:30pm
-
Exploring hospitalizations and visits to the emergency room of patients with Parkinson’s disease: A ten years’ follow-up
- 12:00pm-1:30pm
-
Extended-release carbidopa-levodopa, IPX066: Dosing and efficacy with concomitant medication use in Parkinson’s disease
- 12:00pm-1:30pm
-
Factors affecting the cardiac sympathetic denervation in autopsy confirmed dementia with Lewy bodies
- 12:00pm-1:30pm
-
Factors associated with falling in early, treated Parkinson’s disease: The NET-PD LS1 cohort
- 12:00pm-1:30pm
-
Fall status and stepping response: Individuals with PD are differently influenced by side-affected
- 12:00pm-1:30pm
-
Feasibility and preliminary efficacy of a telehealth approach to group tango instruction for people with Parkinson’s disease
- 12:00pm-1:30pm
-
Feasibility, safety and effects of a group intervention based on European physiotherapy guideline for Parkinson´s disease
- 12:00pm-1:30pm
-
Features of the quality of life and related disorders in patients with focal dystonia
- 12:00pm-1:30pm
-
Fighting Freezing of gait in Parkinson’s disease: Effect of a phase-dependent tactile biofeedback
- 12:00pm-1:30pm
-
Finding an optimal lead trajectory for a better stimulated volume in movement disorder therapy
- 12:00pm-1:30pm
-
Finger tapping-related brain activation and impact of cerebellar theta-burst stimulation in cervical dystonia patients
- 12:00pm-1:30pm
-
Fox insight wear ecosystem: using mobile technology and cloud-based computing to support PD research
- 12:00pm-1:30pm
-
Frequency and types of dystonia in Wilson’s disease patients
- 12:00pm-1:30pm
-
Gait and anthropometric characteristics of patients with Parkinson’s disease seen in a Nigerian tertiary hospital
- 12:00pm-1:30pm
-
Gaze evoked blepharospasm
- 12:00pm-1:30pm
-
Gender-dependent behavioral and biochemical differences in the A53T genetic mouse model of Parkinson’s disease
- 12:00pm-1:30pm
-
Global implementation of efficacious voice treatment for Parkinson’s disease: LSVT LOUD: Germany®
- 12:00pm-1:30pm
-
Has iCare PD started in Singapore?
- 12:00pm-1:30pm
-
Healthcare burden of Parkinson’s disease
- 12:00pm-1:30pm
-
Heterozygous TUBB4A knock-out impairs mitochondrial motility in human neuronal model of DYT4
- 12:00pm-1:30pm
-
Histology of subcutaneous nodules in PD patients treated with continuous apomorphine infusion: Case series and review of the literature
- 12:00pm-1:30pm
-
How satisfied are cervical dystonia patients with their botulinum toxin treatment? Findings from an international observational study
- 12:00pm-1:30pm
-
Hydrogen sulfide functions as a neuromodulator to regulate striatal neurotransmission in a mouse model of Parkinson’s disease
- 12:00pm-1:30pm
-
Impaired response times to luminance stimuli in dystonia patients indicate disordered superior colliculus processing
- 12:00pm-1:30pm
-
Improved motor functioning of people with Parkinson’s disease following dance intervention
- 12:00pm-1:30pm
-
Improvement of foot progression in cervical dystonia using osteopathic manipulative medicine
- 12:00pm-1:30pm
-
Improvement of freezing of gait with intestinal levodopa infusion in advanced Parkinson’s disease patients
- 12:00pm-1:30pm
-
Improvement of levodopa induced foot dystonia with 60 Hz frequency subthalamic- deep brain stimulation
- 12:00pm-1:30pm
-
Improvement of post-stroke fixed dystonia of upper and lower limb following DBS of internal capsule: Report of two cases
- 12:00pm-1:30pm
-
Improving drug discovery using brain oscillations as biomarkers of Parkinson’s disease
- 12:00pm-1:30pm
-
Improving provision of Parkinson’s disease exercise classes
- 12:00pm-1:30pm
-
Improving the experience of diagnosis in Parkinson’s disease
- 12:00pm-1:30pm
-
In-vivo free-water imaging and functional connectivity in a knock-in mouse model of DYT1 dystonia
- 12:00pm-1:30pm
-
Incidence and etiologies of pediatric asterixis
- 12:00pm-1:30pm
-
Incidence of fragility fractures in people with parkinsonism [PwP] – A 5 year retrospective observational study
- 12:00pm-1:30pm
-
Inhibition of cathepsin D enhances the autophagy lysosome pathway dysfunction and α-synuclein aggregation in experimental parkinsonism
- 12:00pm-1:30pm
-
Inhibition of glucosylceramide synthase reduces pathology and improves cognition in synucleinopathy murine models
- 12:00pm-1:30pm
-
Investigating the plastic effects of rapid paired associative stimulation in dystonia
- 12:00pm-1:30pm
-
Investigation of head tremor in cervical dystonia: Novel application of virtual reality head mounted display, the oculus rift
- 12:00pm-1:30pm
-
KINECT 3: A randomized, double-blind, placebo-controlled phase 3 trial of valbenazine (NBI-98854) for tardive dyskinesia
- 12:00pm-1:30pm
-
Levodopa-carbidopa intestinal gel via PEG-J for advanced Parkinson’s disease- A single centre experience
- 12:00pm-1:30pm
-
Levodopa-entacapone-carbidopa intestinal gel in Parkinson’s disease – A randomized, crossover infusion study
- 12:00pm-1:30pm
-
Levodopa/carbidopa intestinal gel treatment in advanced Parkinson’s disease: A long-term observational study
- 12:00pm-1:30pm
-
Levodopa/carbidopa intestinal gel, neuropathy, and B-vitamins – Is there an association?
- 12:00pm-1:30pm
-
Long-term comparative outcomes of functional neurosurgical procedures for treatment of secondary hemidystonia
- 12:00pm-1:30pm
-
Long-term effects of a short inpatient rehabilitation course and peer support in dystonia
- 12:00pm-1:30pm
-
LSVT-BIG© case studies: A snapshot of observations
- 12:00pm-1:30pm
-
May early introduction of dopaminergic agonists improve simptoms after ischemic stroke? The interim report
- 12:00pm-1:30pm
-
Medicinal cannabis for Parkinson’s disease: A survey of practices, beliefs, and attitudes among providers at NPF centers of excellence
- 12:00pm-1:30pm
-
Mental simulation of whole-body movements in patients with isolated cervical dystonia
- 12:00pm-1:30pm
-
Mind the gap: Temporal discrimination and cervical dystonia
- 12:00pm-1:30pm
-
Motor phenotype classification in moderate to advanced PD: Data from the BioFIND study
- 12:00pm-1:30pm
-
Motor variability and learning indices in DYT1 dystonia
- 12:00pm-1:30pm
-
Motor-related brain changes associated with acute administration of trihexyphenidyl in patients with cervical dystonia
- 12:00pm-1:30pm
-
MRI abnormalities and EEG patterns of symptomatic epilepsy in children with cerebral palsy
- 12:00pm-1:30pm
-
Multidisciplinary Parkinson rehabilitation in the Netherlands: The effectiveness of points of Parkinson (POP)
- 12:00pm-1:30pm
-
ND0701: A novel safe concentrated apomorphine formulation for continuous subcutaneous administration via a patch pump
- 12:00pm-1:30pm
-
Negative dystonia of the palate: Mutation in the THAP1 (DYT6) gene found in a 42 years old patient
- 12:00pm-1:30pm
-
New therapeutic algorithm for abnormal posture in Parkinson’s disease and related disorders
- 12:00pm-1:30pm
-
Novel small molecules targeting alpha-synuclein aggregation for the treatment of Parkinson’s disease
- 12:00pm-1:30pm
-
Nursing diagnoses and interventions in rehabilitation related to antiParkinsonian pharmacotherapy
- 12:00pm-1:30pm
-
Objective measures of Parkinsonian motor symptoms using a continuously worn smartwatch
- 12:00pm-1:30pm
-
Ocular flutter in alcohol withdrawal syndrome
- 12:00pm-1:30pm
-
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
- 12:00pm-1:30pm
-
Opicapone in fluctuating Parkinson’s disease patients: OFF- and ON-time responder post-hoc analyses of pooled phase III studies
- 12:00pm-1:30pm
-
Orientation of attention affects onset of head saccades: A novel representation of the Posner cueing effect
- 12:00pm-1:30pm
-
Osmotic demyelination syndrome with dystonia and parkinsonism responsive to dopaminergic therapy
- 12:00pm-1:30pm
-
Osteopathic manipulative treatment in Parkinson’s disease: Preliminary results of a double blind sham-controlled cross-over study
- 12:00pm-1:30pm
-
Outpatient management of Parkinson’s disease: A review of medication changes made to address both motor and non-motor symptoms
- 12:00pm-1:30pm
-
Pallidal low frequency activity correlates with dystonic symptoms in patients with cervical dystonia
- 12:00pm-1:30pm
-
Parietal hand pseudodystonia: Significant functional gains with ultrasound-guided botulinum toxin treatments
- 12:00pm-1:30pm
-
PARK-OMM – An osteopathic manipulative medicine protocol to improve motor function and balance in Parkinson’s disease
- 12:00pm-1:30pm
-
Parkinson patient reported outcomes of voice and communication pre, post and 6 months following LSVT LOUD® and LSVT ARTIC
- 12:00pm-1:30pm
-
Parkinsonian symptoms in patients with cervical dystonia treated with bilateral pallidal deep brain stimulation: A controlled study
- 12:00pm-1:30pm
-
Parkinsonism due to hypermanganism in the background of cirrhosis and recovery by CaNaEDTA
- 12:00pm-1:30pm
-
Participant feedback in the PREDICT-PD study
- 12:00pm-1:30pm
-
Pathological findings from two Parkinson’s disease patients after intraputaminal GDNF infusion
- 12:00pm-1:30pm
-
Patient case reports supporting a long-term effect of sub-anesthetic ketamine infusion in reducing L-DOPA-induced dyskinesias
- 12:00pm-1:30pm
-
Patient experiences following Parkinson’s disease treatment with inhaled levodopa: Results from a Phase 2b study
- 12:00pm-1:30pm
-
Patient satisfaction with flexible botulinum toxin injection intervals – Preliminary results of a telephone survey
- 12:00pm-1:30pm
-
Perception of the visual vertical is not impaired in patients with idiopathic cervical dystonia
- 12:00pm-1:30pm
-
Peri-operative dopaminergic replacement protocol with rotigotine in Parkinson’s disease patients
- 12:00pm-1:30pm
-
Pharmacokinetic profile of ONO-2160/CD (levodopa prodrug/carbidopa) in animal and human
- 12:00pm-1:30pm
-
Phenomenology of idiopathic adult-onset truncal dystonia
- 12:00pm-1:30pm
-
Physiological and biomechanical responses of people with Parkinson’s during Zumba Gold®: Effects of dance styles and number of sessions
- 12:00pm-1:30pm
-
Pre-pulse inhibition of blink reflex in cervical dystonia
- 12:00pm-1:30pm
-
Preclinical evaluation of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias: Is it a ‘chemical’ DBS?
- 12:00pm-1:30pm
-
Predicting medication reduction in Parkinson’s disease patients after deep brain stimulation
- 12:00pm-1:30pm
-
Predicting therapeutic effects of atomoxetine and citalopram on response inhibition in Parkinson’s disease
- 12:00pm-1:30pm
-
Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia
- 12:00pm-1:30pm
-
Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism
- 12:00pm-1:30pm
-
Priapism and hypersexuality associated with rotigotine in an elderly Parkinsonian patient: A case report
- 12:00pm-1:30pm
-
Probable REM sleep behaviour disorder and detrusor overactivity in primary cervical dystonia- A case report
- 12:00pm-1:30pm
-
Profile of urgent care visits in movement disorders
- 12:00pm-1:30pm
-
Progress in the development of small molecules based on the coumarin core as multifunctional neuroprotective agents
- 12:00pm-1:30pm
-
Proprioceptive training as a means to enhance sensorimotor function in Parkinson’s disease
- 12:00pm-1:30pm
-
Pseudodystonic upper limb secondary to thalamic lesions: Usefulness of ultrasound-guided botulinum toxin treatment
- 12:00pm-1:30pm
-
Psychogenic gait disorders in children – Report of 2 cases
- 12:00pm-1:30pm
-
Psychogenic non-epileptic seizures among patients with temporal lobe and other epilepsies: Phenomenology and EEG correlates
- 12:00pm-1:30pm
-
Randomised trial comparing dopamine agonist, MAOB inhibitor and COMT inhibitor as adjuvant therapy in later Parkinson’s disease (PD)
- 12:00pm-1:30pm
-
RE-024: A potential phosphopantothenate replacement therapy in 2 patients with pantothenate kinase-associated neurodegeneration (PKAN)
- 12:00pm-1:30pm
-
Real world conversion of levodopa to a novel extended release levodopa preparation: Determining predictors and dose ratios
- 12:00pm-1:30pm
-
Real-life data on the use of levodopa carbidopa intestinal gel in Parkinson’s disease
- 12:00pm-1:30pm
-
Real-time ultrasound for automated analysis and visualization of neck muscles in cervical dystonia
- 12:00pm-1:30pm
-
Recent result of indicative evaluation for deep brain stimulation of Parkinson’s disease patients
- 12:00pm-1:30pm
-
Reflex saccades changes can estimate long-term symptom progression in DBS STN and MED Parkinson’s disease patients (PD)
- 12:00pm-1:30pm
-
Regional differences in the results of a phase 2b study of tozadenant in Parkinson’s disease patients with motor fluctuations
- 12:00pm-1:30pm
-
Relationship between balance, trunk impairment and hand function in Parkinson’s disease
- 12:00pm-1:30pm
-
Relationship of muscular strength with cardiovascular function in Parkinson’s disease
- 12:00pm-1:30pm
-
Reliability of the sensory organization test to predict falls in individuals with Parkinson’s disease
- 12:00pm-1:30pm
-
Risk factors for premature withdraw from the LS-1 PD study
- 12:00pm-1:30pm
-
Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia
- 12:00pm-1:30pm
-
Role of the nurse coordinator within a unit for treatment of neuro-surgical behaviours and abnormal movements
- 12:00pm-1:30pm
-
Rotigotine transdermal patch in Chinese patients with advanced Parkinson’s disease: A randomized, double-blind study
- 12:00pm-1:30pm
-
Safety and efficacy of pardoprunox for patients with Parkinson’s disease: A meta-analysis
- 12:00pm-1:30pm
-
Safety and tolerability of inhaled levodopa (CVT-301) administered to Parkinson’s disease patients with motor fluctuations
- 12:00pm-1:30pm
-
Safety of opicapone in fluctuating Parkinson’s disease patients: Results of the 1-year extension of study BIPARK I
- 12:00pm-1:30pm
-
Safety, pharmacokinetics, and efficacy of levodopa prodrug ONO-2160/CD: A study in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
Sarcopenia and dynapenia in patients with parkinsonism
- 12:00pm-1:30pm
-
Selective M4 antagonism potentiates L-DOPA-induced dyskinesia in MPTP-treated common marmosets
- 12:00pm-1:30pm
-
Self-perception of vocal handicap in Parkinson’s disease
- 12:00pm-1:30pm
-
Sensor-based motor state detection in Parkinson’s disease to approach personalized therapy delivery
- 12:00pm-1:30pm
-
Sensorimotor gray matter changes in professional brass players with and without Embouchure dystonia
- 12:00pm-1:30pm
-
Sensory gating and inhibition in dystonia
- 12:00pm-1:30pm
-
Sensory tricks in cervical dystonia
- 12:00pm-1:30pm
-
Significant improvement of adult-onset dystonia with cannabinoids-based oromucosal spray
- 12:00pm-1:30pm
-
Smell perception and judgement in PD patients: Results of a study designed, conducted, analysed and reported by PD patients
- 12:00pm-1:30pm
-
Spectrum of acute movement disorders in a pediatric movement disorder clinic; Malaysian experience
- 12:00pm-1:30pm
-
Speech and voice range profile in patients with Parkinson’s disease with deep brain stimulation: Preliminary data
- 12:00pm-1:30pm
-
Status of NPF-QII after six years: Updates to the dataset
- 12:00pm-1:30pm
-
Stiff person syndrome
- 12:00pm-1:30pm
-
Stiff person syndrome: Case series
- 12:00pm-1:30pm
-
Striatal postsynaptic dysfunction in X-linked dystonia-parkinsonism is associated with disease progression
- 12:00pm-1:30pm
-
Structural and connectivity changes after botulinum neurotoxin therapy in blepharospasmus and hemifacial spasm
- 12:00pm-1:30pm
-
Structural organization of the brain connectome in patients with psychogenic dystonia
- 12:00pm-1:30pm
-
Subthalamic deep brain stimulation vs. intraduodenal levodopa infusion: A long-term retrospective comparative study
- 12:00pm-1:30pm
-
Subtle sensory abnormalities in patients with segmental and cervical dystonia detected by quantitative sensory testing
- 12:00pm-1:30pm
-
Successful treatment of movement disorders after resection of midbrain cavernous malformations: Report of two cases
- 12:00pm-1:30pm
-
Suggested criteria for patient selection for therapy with carbidopa/levodopa enteral suspension (CLES)
- 12:00pm-1:30pm
-
Swallowing difficulties in patients with Parkinson’s disease and Parkinsonian syndromes
- 12:00pm-1:30pm
-
Symptoms of dystonia in a mouse with mutation in Lamb1
- 12:00pm-1:30pm
-
Syndrome of dystonia-parkinsonism is a complication of cyclosporine A treatment and may be irreversible
- 12:00pm-1:30pm
-
Synergistic effects of physical therapy and botulinum toxin in primary cervical dystonia
- 12:00pm-1:30pm
-
Systematic literature review of quetiapine for hallucinosis / psychosis in Parkinson’s disease (PD)
- 12:00pm-1:30pm
-
Systems biological approach to Parkinson’s disease- Uncovering effects of PD on the synapse
- 12:00pm-1:30pm
-
Taking specialist clinics into community nursing homes
- 12:00pm-1:30pm
-
Targeting PDE7 by the small molecule S14: A potential disease-modifying Parkinson�s disease therapy ready to start clinical trials
- 12:00pm-1:30pm
-
Temporal discrimination threshold and the menstrual cycle
- 12:00pm-1:30pm
-
The application of mobile health technology to increase physical activity in persons with Parkinson’s disease
- 12:00pm-1:30pm
-
The clinical benefit of pallidal stimulation in dystonia is related to the electrode position in the medio-lateral direction
- 12:00pm-1:30pm
-
The correlation between dietary fiber, fluid intake and constipation in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
The differentiated treatment of Parkinson’s disease in patients with concomitant diabetes mellitus(DM) type 2
- 12:00pm-1:30pm
-
The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients
- 12:00pm-1:30pm
-
The effects of intensive speech treatment on intelligibility in Spanish dysarthria secondary to Parkinson’s disease
- 12:00pm-1:30pm
-
The efficacy of tremor detection and suppression device in intractable rest tremor in patients with Parkinson’s disease
- 12:00pm-1:30pm
-
The influence of cerebellar transcranial direct current stimulation on skill acquisition in Parkinson’s disease
- 12:00pm-1:30pm
-
The Luxembourg Parkinson’s study: Integrating the Lewy body composite risk score into a longitudinal study
- 12:00pm-1:30pm
-
The Parkinson progression marker initiative (PPMI) – Developing a comprehensive longitudinal biomarker dataset
- 12:00pm-1:30pm
-
The potential therapeutic effect of intranasal administration of stem cells in rotenone model of Parkinson’s disease in mice
- 12:00pm-1:30pm
-
The prevalence of non- motor symptoms in dystonia
- 12:00pm-1:30pm
-
The role of acoustic salience in acoustic cueing and sound-based motor rehabilitation
- 12:00pm-1:30pm
-
The sense of agency is altered in cervical dystonia
- 12:00pm-1:30pm
-
The systemic synuclein sampling study (S4)
- 12:00pm-1:30pm
-
The unfolded protein response pathway as a possible therapeutic target for the synucleinopathies
- 12:00pm-1:30pm
-
The writer’s cramp and its connections with sensory deficits
- 12:00pm-1:30pm
-
Therapeutic effect of onabotulinumtoxinA (BoNT/A) in hemifacial spasm and trigeminal neuralgia post Ramsay Hunt Syndrome type II
- 12:00pm-1:30pm
-
Therapeutic potential of compounds preferring specific GABAA receptor subunits for the treatment of dystonia?
- 12:00pm-1:30pm
-
Therapeutic protocol for Parkinson’s patient with freezing based on action observation plus sonification: Preliminary results
- 12:00pm-1:30pm
-
TNF compromises lysosome acidification and reduces α-synuclein degradation via autophagy in dopaminergic cells
- 12:00pm-1:30pm
-
Transcranial versus root repeated magnetic stimulation as a treatment of psychogenic movement disorders
- 12:00pm-1:30pm
-
Unilateral pallidotomy for cervical dystonia
- 12:00pm-1:30pm
-
Upper limb motor tests are related to clinical ratings of motor function in advanced Parkinson’s disease
- 12:00pm-1:30pm
-
Utilization and longitudinal impact of amantadine use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry
- 12:00pm-1:30pm
-
Utilization and longitudinal impact of anticholinergic use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry
- 12:00pm-1:30pm
-
Utilizing remote blood pressure monitoring in a phase III clinical drug trial for Parkinson’s disease
- 12:00pm-1:30pm
-
Validation of the XDP-MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism (XDP)
- 12:00pm-1:30pm
-
Video assessment of writer’s cramp
- 12:00pm-1:30pm
-
Virtual rehabilitation: A therapy for parkinsonism?
- 12:00pm-1:30pm
-
Virtual-reality balance training with Nintendo-Wii games improves dynamic balance in Parkinson’s disease patients
- 12:00pm-1:30pm
-
Voice harmonic amplitude differences before and after LSVT LOUDTM in Parkinson’s disease
- 12:00pm-1:30pm
-
When is the worst period of nocturnal hypokinesia in Parkinson’s disease? A sensor-based analysis
- 12:00pm-1:30pm
-
White matter connectome in patients with genetic dystonia